Dolby Laboratories (DLB) 10-Q 9 Aug 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Jul. 01, 2022	Jul. 29, 2022
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 01, 2022
Document Transition Report	false
Entity File Number	001-32431
Entity Registrant Name	DOLBY LABORATORIES, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	90-0199783
Entity Address, Address Line One	1275 Market Street
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94103-1410
City Area Code	415
Local Phone Number	558-0200
Title of 12(b) Security	Class A common stock, $0.001 par value
Trading Symbol	DLB
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001308547
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A Common Stock [Member]
Entity Common Stock, Shares Outstanding (shares)		61,590,451
Class B Common Stock [Member]
Entity Common Stock, Shares Outstanding (shares)		36,086,129

Interim Condensed Consolidated

Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 01, 2022	Sep. 24, 2021
Current assets:
Cash and cash equivalents	$ 858,905	$ 1,225,380
Restricted cash	8,352	7,652
Short-term investments	156,812	38,839
Accounts receivable, net of allowance for credit losses of $9,572 and $8,744	236,229	232,609
Contract assets, net of allowance for credit losses of $123 and $208	170,402	182,316
Inventories, net	24,096	10,965
Prepaid expenses and other current assets	49,923	62,737
Total current assets	1,504,719	1,760,498
Long-term investments	106,726	62,819
Property, plant and equipment, net	517,870	534,381
Operating lease right-of-use assets	53,702	67,128
Intangible assets, net	119,251	122,890
Goodwill	368,282	340,694
Other non-current assets	65,841	61,257
Deferred taxes	183,545	156,020
Total assets	2,919,936	3,105,687
Current liabilities:
Accounts payable	16,821	17,779
Accrued liabilities	229,267	262,728
Income taxes payable	3,850	1,334
Contract liabilities	21,216	18,473
Operating lease liabilities	14,331	15,403
Total current liabilities	285,485	315,717
Non-current contract liabilities	24,350	23,713
Non-current operating lease liabilities	44,257	56,715
Other non-current liabilities	106,319	105,310
Total liabilities	460,411	501,455
Stockholders’ equity:
Retained earnings	2,484,689	2,607,909
Accumulated other comprehensive loss	(30,426)	(10,030)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,454,361	2,597,979
Controlling interest	5,164	6,253
Total stockholders’ equity	2,459,525	2,604,232
Total liabilities and stockholders’ equity	2,919,936	3,105,687
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 62,578,760 shares issued and outstanding at July 1, 2022 and 64,986,316 at September 24, 2021
Stockholders’ equity:
Common stock	57	59
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,086,629 shares issued and outstanding at July 1, 2022 and 36,086,779 at September 24, 2021
Stockholders’ equity:
Common stock	$ 41	$ 41

Interim Condensed Consolidate_2

Interim Condensed Consolidated Balance Sheets (Parenthetical) $ in Thousands	Jul. 01, 2022 USD ($) vote $ / shares shares	Sep. 24, 2021 USD ($) vote shares
Allowance for doubtful accounts | $	$ 9,572	$ 8,744
Contract assets, allowance for credit losses | $	$ 123	$ 208
Class A Common Stock [Member]
Common stock, par value (usd per share) | $ / shares	$ 0.001
Common stock voting right per share (votes per share) | vote	1
Common stock, shares authorized (shares)	500,000,000	500,000,000
Common stock, shares issued (shares)	62,578,760	64,986,316
Common stock, shares outstanding (shares)	62,578,760	64,986,316
Class B Common Stock [Member]
Common stock, par value (usd per share) | $ / shares	$ 0.001
Common stock voting right per share (votes per share) | vote	10	10
Common stock, shares authorized (shares)	500,000,000	500,000,000
Common stock, shares issued (shares)	36,086,629	36,086,779
Common stock, shares outstanding (shares)	36,086,629	36,086,779

Interim Condensed Consolidate_3

Interim Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021
Revenue:
Revenue	$ 289,585	$ 286,799	$ 975,589	$ 996,231
Total revenue	289,585	286,799	975,589	996,231
Cost of revenue:
Total cost of revenue	35,957	31,644	104,181	99,326
Gross margin	253,628	255,155	871,408	896,905
Operating expenses:
Research and development	62,859	62,094	199,104	191,674
Sales and marketing	87,114	80,714	268,514	234,205
General and administrative	57,113	56,116	218,250	169,968
Gain on sale of assets	0	0	0	(13,871)
Restructuring charges	976	140	6,043	10,904
Total operating expenses	208,062	199,064	691,911	592,880
Operating income	45,566	56,091	179,497	304,025
Other income/(expense):
Interest income	1,416	741	3,230	2,677
Interest expense	(84)	(108)	(255)	(360)
Other income, net	2,514	2,401	1,833	5,112
Total other income	3,846	3,034	4,808	7,429
Income before income taxes	49,412	59,125	184,305	311,454
Provision for income taxes	(9,802)	(4,565)	(28,166)	(37,859)
Net income including controlling interest	39,610	54,560	156,139	273,595
Less: net (income)/loss attributable to controlling interest	(13)	61	192	(7,559)
Net income attributable to Dolby Laboratories, Inc.	$ 39,597	$ 54,621	$ 156,331	$ 266,036
Net income per share:
Basic (in usd per share)	$ 0.40	$ 0.54	$ 1.55	$ 2.63
Diluted (in usd per share)	$ 0.39	$ 0.52	$ 1.52	$ 2.54
Weighted-average shares outstanding:
Basic (in shares)	100,213	101,351	100,936	101,177
Diluted (in shares)	101,474	104,633	102,993	104,607
Cash dividend declared per common share (in dollars per share)	$ 0.25	$ 0.22	$ 0.75	$ 0.66
Cash dividend paid per common share (in dollars per share)	$ 0.25	$ 0.22	$ 0.75	$ 0.66
Licensing
Revenue:
Revenue	$ 269,289	$ 271,569	$ 915,406	$ 948,159
Cost of revenue:
Cost of revenue	13,756	12,480	45,363	41,486
Products and services
Revenue:
Revenue	20,296	15,230	60,183	48,072
Cost of revenue:
Cost of revenue	$ 22,201	$ 19,164	$ 58,818	$ 57,840

Interim Condensed Consolidate_4

Interim Condensed Consolidated Statements of Comprehensive Income Statement - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021
Statement of Comprehensive Income [Abstract]
Net income including controlling interest	$ 39,610	$ 54,560	$ 156,139	$ 273,595
Other comprehensive income:
Currency translation adjustments gains/(losses), net of tax expense of $0, ($110), $0, and ($617)	(14,086)	898	(15,842)	8,300
Unrealized losses on investments, net of tax benefit/(expense) of $3, $42, ($2), and $88	(426)	(162)	(4,446)	(522)
Unrealized losses on cash flow hedges, net of tax benefit/(expense) of $178, ($123), $98, and ($453)	(498)	(1,658)	(320)	(1,876)
Other Comprehensive Income (Loss), Net of Tax	(15,010)	(922)	(20,608)	5,902
Comprehensive income	24,600	53,638	135,531	279,497
Less: comprehensive (income) attributable to controlling interest	252	(10)	404	(7,899)
Comprehensive income attributable to Dolby Laboratories, Inc.	$ 24,852	$ 53,628	$ 135,935	$ 271,598

Interim Condensed Consolidate_5

Interim Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021
Statement of Comprehensive Income [Abstract]
Currency translation adjustment, tax	$ 0	$ (110)	$ 0	$ (617)
Unrealized gain (loss) on investments, tax	3	42	(2)	88
Unrealized gains on cash flow hedges, tax	$ 178	$ (123)	$ 98	$ (453)

Interim Condensed Consolidate_6

Interim Condensed Consolidated Statements Of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Common Stock Class A Common Stock [Member]	Additional Paid-In Capital	Additional Paid-In Capital Class A Common Stock [Member]	Retained Earnings	Accumulated Other Comprehensive Loss	Total Stockholders' Equity - Dolby Laboratories, Inc.	Controlling Interest
Beginning balance (in shares) at Sep. 25, 2020		99,000
Beginning balance at Sep. 25, 2020	$ 2,438,405			$ 0		$ 2,443,138	$ (10,594)	$ 2,432,643	$ 5,762
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	273,595					266,036		266,036	7,559
Other comprehensive income/(loss), net of tax	5,902						5,562	5,562	340
Distributions to controlling interest	(7,362)								(7,362)
Stock-based compensation expense	75,562			75,562				75,562
Repurchase of common stock (in shares)		(2,000)
Repurchase of common stock	(149,764)			(133,918)		(15,844)		(149,764)
Cash dividends declared and paid on common stock	(66,883)					(66,883)		(66,883)
Common stock issued under employee stock plans (in shares)			3,000
Common stock issued under employee stock plans	89,148			89,145				89,148
Tax withholdings on vesting of restricted stock (in shares)			0
Tax withholdings on vesting of restricted stock	(30,789)				$ (30,789)			(30,789)
Ending balance (in shares) at Jun. 25, 2021		100,000
Ending balance at Jun. 25, 2021	2,627,814			0		2,626,447	(5,032)	2,621,515	6,299
Beginning balance (in shares) at Mar. 26, 2021		100,000
Beginning balance at Mar. 26, 2021	2,594,220			0		2,591,870	(4,039)	2,587,931	6,289
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	54,560					54,621		54,621	(61)
Other comprehensive income/(loss), net of tax	(922)						(993)	(993)	71
Stock-based compensation expense	24,836			24,836				24,836
Repurchase of common stock (in shares)		(1,000)
Repurchase of common stock	(38,989)			(41,253)		2,265		(38,989)
Cash dividends declared and paid on common stock	(22,309)					(22,309)		(22,309)
Common stock issued under employee stock plans (in shares)			1,000
Common stock issued under employee stock plans	17,991			17,990				17,991
Tax withholdings on vesting of restricted stock (in shares)			0
Tax withholdings on vesting of restricted stock	(1,573)				(1,573)			(1,573)	0
Ending balance (in shares) at Jun. 25, 2021		100,000
Ending balance at Jun. 25, 2021	2,627,814			0		2,626,447	(5,032)	2,621,515	6,299
Beginning balance (in shares) at Sep. 24, 2021		100,000
Beginning balance at Sep. 24, 2021	2,604,232			0		2,607,909	(10,030)	2,597,979	6,253
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	156,139					156,331		156,331	(192)
Other comprehensive income/(loss), net of tax	(20,608)						(20,396)	(20,396)	(212)
Distributions to controlling interest	(1,435)								(1,435)
Stock-based compensation expense	$ 87,963			87,963				87,963
Repurchase of common stock (in shares)	(4,074,014)	(4,000)
Repurchase of common stock	$ (310,486)			(107,567)		(202,915)		(310,486)
Cash dividends declared and paid on common stock	(75,816)					(75,816)		(75,816)
Common stock issued under employee stock plans	53,600	$ 2		53,598				53,600
Tax withholdings on vesting of restricted stock	(33,994)				(33,994)			(33,994)
Deconsolidation of subsidiary	(70)					(820)		(820)	750
Ending balance (in shares) at Jul. 01, 2022		98,000
Ending balance at Jul. 01, 2022	2,459,525			0		2,484,689	(30,426)	2,454,361	5,164
Beginning balance (in shares) at Apr. 01, 2022		99,000
Beginning balance at Apr. 01, 2022	2,605,188			0		2,615,354	(15,681)	2,599,772	5,416
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	39,610					39,597		39,597	13
Other comprehensive income/(loss), net of tax	(15,010)						(14,745)	(14,745)	(265)
Stock-based compensation expense	27,608			27,608				27,608
Repurchase of common stock (in shares)		(2,000)
Repurchase of common stock	(190,000)			(44,871)		(145,127)		(190,000)
Cash dividends declared and paid on common stock	(25,135)					(25,135)		(25,135)
Common stock issued under employee stock plans	18,538	$ 1		18,537				18,538
Tax withholdings on vesting of restricted stock	(1,274)				$ (1,274)			(1,274)
Ending balance (in shares) at Jul. 01, 2022		98,000
Ending balance at Jul. 01, 2022	$ 2,459,525			$ 0		$ 2,484,689	$ (30,426)	$ 2,454,361	$ 5,164

Interim Condensed Consolidate_7

Interim Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021
Operating activities:
Net income including controlling interest	$ 156,139	$ 273,595
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	69,382	70,701
Stock-based compensation	87,963	75,562
Amortization of operating lease right-of-use assets	11,658	12,744
Amortization of premium on investments	1,109	1,051
Provision for/(benefit from) credit losses	2,166	(567)
Deferred income taxes	(29,143)	(26,479)
Gain on sale of assets	0	(13,871)
Other non-cash items affecting net income	(2,388)	(3,293)
Changes in operating assets and liabilities:
Accounts receivable, net	(5,395)	(93,848)
Contract assets, net	11,999	(5,402)
Inventories	(12,231)	14,828
Operating lease right-of-use assets	(941)	(4,982)
Prepaid expenses and other assets	(1,169)	15,468
Accounts payable and accrued liabilities	(29,782)	31,788
Income taxes, net	17,023	4,293
Contract liabilities	3,314	512
Operating lease liabilities	(10,539)	(7,507)
Other non-current liabilities	(1,898)	(6,613)
Net cash provided by operating activities	267,267	337,980
Investing activities:
Purchases of marketable securities	(248,156)	(48,066)
Proceeds from sales of marketable securities	8,970	7,332
Proceeds from maturities of marketable securities	75,890	37,040
Purchases of property, plant, and equipment	(37,218)	(42,619)
Proceeds from sale of assets	0	16,365
Payments for business combinations, net of cash acquired	(38,171)	0
Purchases of intangible assets	(11,528)	0
Purchases of other investments	(5,000)	0
Net cash used in investing activities	(255,213)	(29,948)
Financing activities:
Proceeds from issuance of common stock	53,600	89,148
Repurchase of common stock	(310,486)	(149,764)
Payment of cash dividend	(75,816)	(66,883)
Distribution to controlling interest	(1,435)	(7,362)
Shares repurchased for tax withholdings on vesting of restricted stock	(33,994)	(30,789)
Net cash used in financing activities	(368,131)	(165,650)
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash	(9,698)	4,891
Net increase/(decrease) in cash, cash equivalents, and restricted cash	(365,775)	147,273
Cash, cash equivalents, and restricted cash at beginning of period	1,233,032	1,079,979
Cash, cash equivalents, and restricted cash at end of period	867,257	1,227,252
Supplemental disclosure:
Cash paid for income taxes, net of refunds received	30,014	45,713
Non-cash investing activities and financing activities:
Change in property, plant, and equipment purchased, unpaid at period-end	$ (2,897)	$ 1,230

Interim Condensed Consolidate_8

Interim Condensed Consolidated Statements Of Operations (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021
Related party rent expense:
Included in operating expenses	$ 0	$ (5)	$ 0	$ (392)
Included in net income attributable to controlling interest	$ 71	$ 71	$ 213	$ 311

Basis Of Presentation

Basis Of Presentation	9 Months Ended
	Jul. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis Of Presentation	Basis of Presentation Unaudited Interim Condensed Consolidated Financial Statements We have prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with U.S. GAAP, and with SEC rules and regulations, which allow for certain information and footnote disclosures that are normally included in annual financial statements prepared in accordance with U.S. GAAP to be condensed or omitted. In our opinion, these unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements for the fiscal year ended September 24, 2021 and include all adjustments necessary for fair presentation. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with our consolidated financial statements for the fiscal year ended September 24, 2021, which are included in our Annual Report on Form 10-K filed with the SEC. The results for the fiscal quarter and year-to-date period ended July 1, 2022 are not necessarily indicative of the results to be expected for any subsequent quarterly or annual financial period, including the fiscal year ending September 30, 2022. Principles of Consolidation The unaudited interim condensed consolidated financial statements include the accounts of Dolby Laboratories, Inc. and our wholly owned subsidiaries. In addition, we have consolidated the financial results of jointly owned affiliated companies in which our principal stockholder has a controlling interest. We report these controlling interests as a separate line in our condensed consolidated statements of operations as net income attributable to controlling interest and in our condensed consolidated balance sheets as a controlling interest. We eliminate all intercompany accounts and transactions upon consolidation. Operating Segments Since we operate as a single reportable segment, all required financial segment information is included in our unaudited interim condensed consolidated financial statements. This reflects the fact that our CODM, our CEO, evaluates our financial information and resources, and assesses the performance of these resources on a consolidated basis. Use of Estimates The preparation of our financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts reported and disclosed in our unaudited interim condensed consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include estimated shipments by our licensees for which we are owed a sales-based royalty. These estimates involve the use of historical data and judgment for several key attributes including industry estimates of expected shipments, the percentage of markets using our technologies, and average sale prices. Our estimates of royalty-based revenue also take into consideration the macroeconomic effect of global events, such as the coronavirus pandemic ("COVID-19") or other natural disasters which may impact our licensees' supply chain activities as well as demand for shipments. Additional significant items subject to such estimates and assumptions include ESPs for performance obligations within revenue arrangements; allowances for credit losses for accounts receivable; carrying values of inventories and certain PP&E, goodwill and intangible assets; fair values of investments; accrued liabilities including unrecognized tax benefits, deferred income tax assets and liabilities, and contingent liabilities; and stock-based compensation. Actual results could differ from our estimates. Fiscal Year

Summary Of Significant Accounti

Summary Of Significant Accounting Policies	9 Months Ended
	Jul. 01, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Recently Issued Accounting Standards Adopted Standards Income Taxes. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which modifies and eliminates certain exceptions to the general principles of ASC 740, Income Taxes. We adopted this standard in the first quarter of fiscal 2022, and it did not have a material impact on our condensed consolidated financial statements. Standards Not Yet Adopted Business Combinations. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): A ccounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by an acquirer in accordance with ASC 606, Revenue from Contracts with Customers

Revenue Recognition

Revenue Recognition	9 Months Ended
	Jul. 01, 2022
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition We enter into revenue arrangements with our customers to license technologies, trademarks and patents for sound, imaging and voice solutions, and to sell products and services. We recognize revenue when we satisfy a performance obligation by transferring control over the use of a license, product , or service to a customer. A. Identification of the Contract or Contracts with Customers We generally determine that a contract with a customer exists upon the execution of an agreement and after consideration of collectability, which could include an evaluation of the customer's payment history, the existence of a standby letter-of-credit between the customer’s financial institution and our financial institution, public financial information, and other factors. At contract inception, we also evaluate whether two or more non-standard agreements with a customer should be combined and accounted for as a single contract. B. Identification of Performance Obligations in a Contract We generate revenue principally from the following sources, which represent performance obligations in our contracts with customers: • Licensing. We license our technologies , including patents , to a range of customers who incorporate them into their products for enhanced audio, imaging and voice functionality across broadcast, mobile, CE, PC, gaming, and other markets. • Product Sales. We design and provide audio and imaging products for the cinema, television, broadcast, communications, and entertainment industries. • Services. We provide various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment, including equipment training , mixing room alignment, equalization, as well as audio, color and light image calibration. We also offer a developer platform, Dolby.io, that enables developers to access our technologies through audio and video APIs for building high-quality communications, media, and streaming solutions. • PCS. We provide PCS for products sold and for equipment leased, and we support the implementation of our licensing technologies in our licensees’ products. • Equipment Leases. We collaborate with established cinema exhibitors to offer Dolby Cinema, a branded premium cinema offering for movie audiences by leasing equipment and licensing our IP. We also lease hardware that facilitates the Dolby conferencing experience, including the Dolby Conference Phone, and the Dolby Voice Room solution. • Licensing Administration Fees. We generate service fees for managing patent pools on behalf of third party patent owners through our wholly-owned subsidiary, Via Licensing Corporation ("Via"). Some of our revenue arrangements include multiple performance obligations, such as hardware, software, support and maintenance, and extended warranty services. We evaluate whether promised products and services are distinct performance obligations. The majority of our arrangements with multiple performance obligations pertain to our digital cinema server and processor sales that include the following distinct performance obligations to which we allocate portions of the transaction price based on their stand-alone selling price: • Digital cinema server hardware and embedded software, which is dependent on and interrelated with the hardware. Accordingly, the hardware and embedded software represent a single performance obligation. • The right to support and maintenance, which is included with the purchase of the digital cinema server hardware, is a distinct performance obligation. • The right to receive commissioning services is a distinct performance obligation within the sale of the Dolby Atmos Cinema Processor. These services consist of the review of venue designs specifying proposed speaker placement as well as calibration services performed for installed speakers to ensure optimal playback. C. Determination of Transaction Price for Performance Obligations in a Contract After identifying the distinct performance obligations, we determine the transaction price in accordance with the terms of the underlying executed contract which may include variable consideration such as discounts, rebates, refunds, rights of returns, and incentives. We assess and update, if necessary, the amount of variable consideration to which we are entitled for each reporting period. At the end of each reporting period, we estimate and accrue a liability for returns and adjustments as a reduction to revenue based on several factors, including past returns history. With the exception of our sales-based royalties, we evaluate whether a significant financing component exists when we recognize revenue in advance of customer payments that occur over time. For example, some of our licensing arrangements include payment terms greater than one year from when we transfer control of our IP to a licensee and the receipt of the final payment for that IP. If a significant financing component exists, we classify a portion of the transaction price as interest income, instead of recognizing all of the transaction price as revenue. We do not adjust the transaction price for the effects of financing if, at contract inception , the period between the transfer of control to a customer and final payment is expected to be one year or less. D. Allocation of Transaction Price to Distinct Performance Obligations in a Contract For our sales-based royalties where the license is the predominant item to which the royalties relate, we present all revenue as licensing. For revenue arrangements that include multiple performance obligations, we determine the stand-alone selling price for each distinct performance obligation based on the actual selling prices made to customers. If the performance obligation is not sold separately, we estimate the stand-alone selling price. We do so by considering market conditions such as competitor pricing strategies, customer specific information and industry technology lifecycles, internal conditions such as cost and pricing practices, or applying the residual approach method when the selling price of the good, most commonly a license, is highly variable or uncertain. Once the transaction price, including any variable consideration, has been determined, we allocate the transaction price to the performance obligations identified in the contract, and recognize revenue as or when control is transferred for each distinct performance obligation. E. Revenue Recognition as Control is Transferred to a Customer We generate our licensing revenue by licensing our technologies and patents to various types of licensees, such as chip manufacturers ("implementation licensees"), consumer product manufacturers, software vendors, and communications service providers. Our revenue recognition policies for each of these arrangements are summarized below. Initial fees from implementation licensees. Implementation licensees incorporate our technologies into their chipsets that, once approved by Dolby, are available for purchase by OEMs for use in end-user products. Implementation licensees only pay us a nominal initial fee on contract execution as consideration for the ongoing services that we provide to assist in their implementation process. Revenue from these initial fees is recognized ratably over the contractual term as a component of licensing revenue. Sales-based licensing fees. In our royalty bearing licensing agreements with OEMs, control is transferred upon the later of contract execution or the contract’s effective date. We apply the royalty exception, which requires that we recognize sales-based royalties when the sales occur based on our estimates. These estimates involve the use of historical data and judgment for several key attributes including industry estimates of expected shipments, the percentage of markets using our technologies, and average sale prices. Generally, our estimates represent the current period’s shipments to which we expect our licensees to submit royalty statements in the following quarter. Upon receipt of royalty statements from the licensees with the actual reporting of sales-based royalties that we estimated previously, we record a favorable or unfavorable adjustment based on the difference, if any, between estimated and actual sales. In the third quarter of fiscal 2022, we recorded an favorable adjustment of approximately $3 million, which was primarily related to January through March shipments and largely based on actual royalty statements received from licensees. Fixed and guaranteed licensing fees. In certain cases, our arrangements require the licensee to pay fixed, non-refundable fees. In these cases, control is transferred and fees are recognized upon the later of contract execution or the effective date. Additionally and separate from initial fees from implementation licensees, our sales- and usage-based licensing agreements include a nominal fee, which is also recognized at a point in time in which control of the IP has been transferred. Revenue from these arrangements is included as a component of licensing revenue. Recoveries. Through compliance efforts, we identify misreported licensed activity related to non-current periods. We may record a favorable or unfavorable revenue adjustment in connection with the findings from these compliance efforts generally upon resolution with the licensee through agreement of the findings, or upon receipt of the licensee’s correction statement. Revenue from these arrangements is included as a component of licensing revenue. We undertake activities aimed at identifying potential unauthorized uses of our technologies, which when successful result in the recognition of revenue. Recoveries stem from third parties who agree to remit payments to us based on past use of our technology. In these scenarios, a legally binding contract did not exist at time of use of our technology, and therefore, we recognize revenue recoveries upon execution of the agreement as that is the point in time to which a contract exists and control is transferred. This revenue is classified as licensing revenue. In general, we classify legal costs associated with activities aimed at identifying potential unauthorized uses of our technologies, auditing existing licensees, and on occasion, pursuing litigation as S&M in our condensed consolidated statements of operations. We recognize licensing revenue gross of withholding taxes, which our licensees remit directly to their local tax authorities, and for which we receive a partial foreign tax credit in our income tax provision. In addition to our licensing arrangements, we also enter into arrangements to deliver products and services. Product Sales. Revenue from the sale of products is recognized when the customer obtains control of the promised good or service, which is generally upon shipment. Payments are generally made within 90 days of sale. Services. We provide various services, such as engineering services related to movie soundtrack print mastering, equipment training and maintenance, mixing room alignment, equalization, and image calibration, which we bill on a fixed fee and time and materials basis. Most of these services are of a short duration and are recognized as control of the performance obligations are transferred which is when the related services are performed. Cloud Services. We provide access to audio and video APIs through our developer platform as well as cloud encoding services, generally, on either a consumption or subscription basis. Revenue related to cloud services provided on a consumption basis is recognized when the customer utilizes the services, based on the quantity of services consumed. Revenue related to cloud services provided on a subscription basis is recognized ratably over the contract term as the customer receives and consumes the benefits of the cloud services. Collaborative Arrangements. We collaborate with established cinema exhibitors to offer Dolby Cinema, a branded premium cinema offering for movie audiences. Under such collaborations, Dolby and the exhibitor are both active participants, and share the risks and rewards associated with the business. Accordingly, these collaborations are governed by revenue sharing arrangements under which Dolby receives revenue based on box office receipts, reported to Dolby by exhibitor partners on a monthly or quarterly basis, our proprietary designs and trademarks as well as for the use of our equipment at the exhibitor's venue. The use of our product solution meets the definition of a lease, and for the related portion of Dolby's share of revenue, we apply ASC 842, Leases , and recognize revenue based on monthly box office reports from exhibitors. Our revenue share is recognized as licensing revenue in our condensed consolidated statements of operations. In addition, we also enter into hybrid agreements where a portion of our revenue share involves guaranteed payments, which in some cases result in classifying the arrangement as a sales-type lease. In such arrangements, we consider control to transfer at the point in time to which we have installed and tested the equipment, at which point we record such guaranteed payments as product revenue. Via Administration Fee. We generate service fees for managing patent pools on behalf of third party patent owners through our wholly-owned subsidiary, Via. As an agent to licensors in the patent pool, Via receives a share of the sales-based royalty that the patent pool licensors earn from licensees. As such, we apply the sales-based royalty exception as the service provided is directly related to the patent pool licensors’ provision of IP, which results in recognition based on estimates of the licensee’s quarter shipments that use the pool’s patents. In addition to sales-based royalties, Via also has contracts where the fees are fixed. The revenue share Via receives from licensors on fixed fee contracts is recognized over the term in which we are providing services associated with the fixed fee contract. We recognize our administrative fees net of the consideration paid to the patent licensors in the pool as licensing revenue. Deferred revenue, which is a component of contract liabilities, represents amounts that are ultimately expected to be recognized as revenue, but for which we have yet to satisfy the performance obligation. As of July 1, 2022, we had $44.4 million of remaining performance obligations, 20% of which we expect to recognize as revenue in fiscal 2022, 31% in fiscal 2023, and the balance of 49% in fiscal years beyond 2023. F. Disaggregation of revenue The following table presents a summary of the composition of our revenue for all periods presented (in thousands, except percentage amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended Revenue July 1, 2022 June 25, 2021 July 1, 2022 June 25, 2021 Licensing $ 269,289 93 % $ 271,569 95 % $ 915,406 94 % $ 948,159 95 % Products and services 20,296 7 % 15,230 5 % 60,183 6 % 48,072 5 % Total revenue $ 289,585 100 % $ 286,799 100 % $ 975,589 100 % $ 996,231 100 % The following table presents the composition of our licensing revenue for all periods presented (in thousands, except percentage amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended Market July 1, 2022 June 25, 2021 July 1, 2022 June 25, 2021 Broadcast $ 99,327 37 % $ 123,955 46 % $ 325,441 36 % $ 368,068 39 % Mobile 63,237 23 % 49,861 18 % 204,212 22 % 221,157 23 % CE 38,663 14 % 37,805 14 % 150,192 16 % 138,010 15 % PC 26,947 10 % 24,870 9 % 119,190 13 % 108,709 11 % Other 41,115 16 % 35,078 13 % 116,371 13 % 112,215 12 % Total licensing revenue $ 269,289 100 % $ 271,569 100 % $ 915,406 100 % $ 948,159 100 % We license our technologies in approximately 70 countries, and our licensees distribute products that incorporate our technologies throughout the world. We generate the majority of our revenue from outside the United States ("U.S."). Geographic data for our licensing revenue is based on the location of our licensees’ headquarters, products revenue is based on the destination to which we ship our products, and services revenue is based on the location where services are performed. The following table presents the composition of our revenue by geographic location for all periods presented (in thousands, except percentage amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended Revenue By Geographic Location July 1, 2022 June 25, 2021 July 1, 2022 June 25, 2021 United States $ 78,471 27 % $ 73,355 26 % $ 375,680 39 % $ 327,696 33 % International 211,114 73 % 213,444 74 % 599,909 61 % 668,535 67 % Total revenue $ 289,585 100 % $ 286,799 100 % $ 975,589 100 % $ 996,231 100 % G. Contract balances Our contract assets represent rights to consideration from licensees for the use of our IP that we have estimated in a given period in the absence of receiving actual royalty statements from licensees. These estimates reflect our best judgment at that time, and are developed using a number of inputs, including historical data, industry estimates of expected shipments, anticipated sales price and performance, and third-party data supporting the percentage of markets using our technologies . In the event that our estimates differ from actual amounts reported, we record an adjustment in the quarter in which the royalty statement is received, which is typically the quarter following our estimate. Actual amounts reported are typically paid within 60 days following the end of the quarter of shipment. The main drivers for change in the contract assets account are variances in quarterly estimates, and to a lesser degree, timing of receipt of actual royalty statements. Our contract liabilities consist of advance payments and billings in advance of performance, deferred revenue that is typically satisfied within one year, and deferred interest where we have significant financing. The non-current portion of contract liabilities is separately disclosed in our condensed consolidated balance sheets. We present the net contract asset or liability when we have both contract assets and contract liabilities for a single contract. We recognized $2.1 million in the third quarter of fiscal 2022 and $14.2 million in the fiscal year-to-date period ended July 1, 2022 from prior period deferred revenue. The following table presents a summary of the balances to which contract assets and liabilities related to revenue are recorded for all periods presented (in thousands, except percentage amounts): July 1, 2022 September 24, 2021 Change ($) Change (%) Accounts receivable, net $ 236,229 $ 232,609 $ 3,620 2 % Contract assets, net 170,402 182,316 (11,914) (7) % Contract liabilities - current 21,216 18,473 2,743 15 % Contract liabilities - non-current 24,350 23,713 637 3 %

Composition Of Certain Financia

Composition Of Certain Financial Statement Captions	9 Months Ended
	Jul. 01, 2022
Composition Of Certain Financial Statement Captions [Abstract]
Composition Of Certain Financial Statement Captions	Composition of Certain Financial Statement Captions The following tables present detailed information from our condensed consolidated balance sheets as of July 1, 2022 and September 24, 2021 (in thousands). Accounts Receivable and Contract Assets July 1, September 24, Trade accounts receivable $ 148,665 $ 160,112 Accounts receivable from patent administration program licensees 97,136 81,241 Contract assets 170,525 182,524 Accounts receivable, gross and contract assets, gross 416,326 423,877 Less: allowance for credit losses on accounts receivable and contract assets (9,695) (8,952) Total accounts receivable and contract assets, net $ 406,631 $ 414,925 Accounts receivable, gross includes unbilled accounts receivable balances of $116.6 million and $97.5 million as of July 1, 2022 and September 24, 2021, respectively, related to amounts that are contractually owed. The unbilled balance represents our unconditional right to consideration related to fixed fee contracts which we are entitled to as a result of satisfying, or partially satisfying, performance obligations, as well as Via's unconditional right to consideration related to their patent administration programs. Allowance for Credit Losses Beginning Balance Charges/(Credits) Additions/(Deductions) Ending Balance For fiscal year-to-date period ended: September 24, 2021 $ 15,908 $ (2,889) $ (4,067) $ 8,952 July 1, 2022 8,952 2,166 (852) 10,266 Allowance for credit losses includes the provision for estimated credit losses on our sales-type leases, which was not material as of July 1, 2022 and as of September 24, 2021. Inventories July 1, September 24, Raw materials $ 12,685 $ 2,792 Work in process 4,697 3,461 Finished goods 6,714 4,712 Total inventories $ 24,096 $ 10,965 Inventories are stated at the lower of cost and net realizable value. Inventory with a consumption period expected to exceed twelve months is recorded within other non-current assets in our condensed consolidated balance sheets. We have included $1.3 million and $1.9 million of raw materials inventory within non-current assets as of July 1, 2022 and September 24, 2021, respectively. Based on anticipated inventory consumption rates, and aside from existing write-downs due to excess inventory, we do not believe that material risk of obsolescence exists prior to ultimate sale. Prepaid Expenses And Other Current Assets July 1, September 24, Prepaid expenses $ 28,438 $ 29,964 Other current assets 21,485 32,773 Total prepaid expenses and other current assets $ 49,923 $ 62,737 Accrued Liabilities July 1, September 24, Amounts payable to patent administration program partners $ 77,465 $ 72,847 Accrued compensation and benefits 73,518 107,322 Accrued professional fees 11,802 11,737 Unpaid property, plant, and equipment additions 16,313 17,839 Accrued customer refunds 4,902 14,151 Accrued market development funds 7,728 7,777 Other accrued liabilities 37,539 31,055 Total accrued liabilities $ 229,267 $ 262,728 Other Non-Current Liabilities July 1, September 24, Supplemental retirement plan obligations $ 4,266 $ 4,877 Non-current tax liabilities (1) 88,801 85,063 Other liabilities 13,252 15,370 Total other non-current liabilities $ 106,319 $ 105,310 (1) Refer to Note 12 " Income Taxes " for additional information related to our tax liabilities.

Investments & Fair Value Measur

Investments & Fair Value Measurements	9 Months Ended
	Jul. 01, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]
Investments & Fair Value Measurements	Investments and Fair Value Measurements We use cash holdings to purchase investment grade securities diversified among security types, industries, and issuers. All of our investments in debt securities are measured at fair value, and are recorded within cash equivalents and both short-term and long-term investments in our condensed consolidated balance sheets. With the exception of our mutual fund investments held in our SERP and classified as trading securities and our other long-term investments, all of our investments are classified as AFS securities. Derivative contracts are used to hedge currency risk, and these are carried at fair value and classified as other assets and other liabilities. Our investments in debt securities primarily consist of corporate bonds, municipal debt securities, government bonds, commercial paper, U.S. agency securities, and certificates of deposit. In addition, our cash and cash equivalents also consist of highly-liquid money market funds. Consistent with our investment policy, none of our municipal debt investments are supported by letters of credit or standby purchase agreements. Our cash and investment portfolio consisted of the following (in thousands): July 1, 2022 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 745,010 $ — $ — $ 745,010 $ 745,010 $ — $ — Cash equivalents: Commercial paper 13,523 — — 13,523 — 13,523 — Money market funds 84,724 — — 84,724 84,724 — — Municipal debt securities 1,003 — — 1,003 — 1,003 — Government bonds 419 — — 419 419 — — U.S. agency securities 14,230 — (4) 14,226 — 14,226 — Cash and cash equivalents 858,909 — (4) 858,905 830,153 28,752 — Short-term investments: Certificate of deposit 15,850 1 (31) 15,820 — 15,820 — U.S. agency securities 1,401 — (16) 1,385 — 1,385 — Government bonds 34,081 — (500) 33,581 29,688 3,893 — Commercial paper 16,092 — (31) 16,061 — 16,061 — Corporate bonds 62,687 — (667) 62,020 — 62,020 — Municipal debt securities 27,992 14 (61) 27,945 — 27,945 — Short-term investments 158,103 15 (1,306) 156,812 29,688 127,124 — Long-term investments: U.S. agency securities 860 — (30) 830 — 830 — Government bonds 44,157 1 (1,548) 42,610 39,913 2,697 — Corporate bonds 26,273 — (980) 25,293 — 25,293 — Municipal debt securities 27,733 59 (383) 27,409 — 27,409 — Other investments (1) 10,584 — — 10,584 — — — Long-term investments 109,607 60 (2,941) 106,726 39,913 56,229 — Total cash, cash equivalents, and investments $ 1,126,619 $ 75 $ (4,251) $ 1,122,443 $ 899,754 $ 212,105 $ — Investments held in supplemental retirement plan: Assets $ 4,364 $ — $ — $ 4,364 $ 4,364 $ — $ — Included in prepaid expenses and other current assets and other non-current assets Liabilities $ 4,364 $ — $ — $ 4,364 $ 4,364 $ — $ — Included in accrued liabilities and other non-current liabilities Currency derivatives as hedge instruments: Assets: Included in other current assets $ — $ 353 $ — $ 353 $ — $ 353 $ — Assets: included in other non-current assets — 119 — 119 — 119 — Liabilities: Included in other accrued liabilities — — (1,318) (1,318) — (1,318) — (1) Other investments as of July 1, 2022 is comprised of an equity method investment and an equity security without a readily determinable fair value measured under the "measurement alternative" (at cost, minus impairment or adjusted for any observable price changes). The equity method investment is measured at cost minus impairment, if any, adjusted for our proportionate share of the investee's net income or loss. Our share of the equity method investee's net income or loss is included in other income/(expense), net on the condensed consolidated statements of operations, and was $3.1 million in the third quarter of fiscal 2022 and was $3.5 million in the year-to-date period ended July 1, 2022. September 24, 2021 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 990,182 $ — $ — $ 990,182 $ 990,182 $ — $ — Cash equivalents: Money market funds 235,198 — — 235,198 235,198 — — Cash and cash equivalents 1,225,380 — — 1,225,380 1,225,380 — — Short-term investments: Certificate of deposit 1,795 — — 1,795 — 1,795 — U.S. agency securities 1,096 6 — 1,102 — 1,102 — Government bonds 100 2 — 102 102 — — Commercial paper 5,184 2 — 5,186 — 5,186 — Corporate bonds 18,850 116 — 18,966 — 18,966 — Municipal debt securities 11,660 29 (1) 11,688 — 11,688 — Short-term investments 38,685 155 (1) 38,839 102 38,737 — Long-term investments: U.S. agency securities 2,264 13 (2) 2,275 — 2,275 — Government bonds 11,784 38 (16) 11,806 4,966 6,840 — Corporate bonds 32,116 61 (25) 32,152 — 32,152 — Municipal debt securities 10,080 58 (8) 10,130 — 10,130 — Other investments (1) 6,456 — — 6,456 — — — Long-term investments 62,700 170 (51) 62,819 4,966 51,397 — Total cash, cash equivalents, and investments $ 1,326,765 $ 325 $ (52) $ 1,327,038 $ 1,230,448 $ 90,134 $ — Investments held in supplemental retirement plan: Assets $ 4,975 $ — $ — $ 4,975 $ 4,975 $ — $ — Included in prepaid expenses and other current assets and other non-current assets Liabilities $ 4,975 $ — $ — $ 4,975 $ 4,975 $ — $ — Included in accrued liabilities and other non-current liabilities Currency derivatives as hedge instruments: Assets: Included in other current assets $ — $ 689 $ — $ 689 $ — $ 689 $ — Liabilities: Included in other accrued liabilities — — (197) (197) — (197) — (1) Other investments as of September 24, 2021 is comprised of one equity method investment, which is measured at cost minus impairment, if any, adjusted for our proportionate share of the investee’s net income or loss. Our share of the investee's net income or loss was not material in the third quarter of fiscal 2021 and was $3.7 million in the year-to-date period ended June 25, 2021. Fair Value Hierarchy. Fair value is the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants at the measurement date. We minimize the use of unobservable inputs and use observable market data, if available, when determining fair value. We classify our inputs to measure fair value using the following three-level hierarchy: Level 1: Quoted prices in active markets at the measurement date for identical assets and liabilities. We base the fair value of our Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments. Level 2: Prices may be based upon quoted prices in active markets or inputs not quoted on active markets but are corroborated by market data. We obtain the fair value of our Level 2 financial instruments from a professional pricing service, which may use quoted market prices for identical or comparable instruments, or model driven valuations using observable market data or inputs corroborated by observable market data. To validate the fair value determination provided by our primary pricing service, we perform quality controls over values received which include comparing our pricing service provider’s assessment of the fair values of our investment securities against the fair values of our investment securities obtained from another independent source, reviewing the pricing movement in the context of overall market trends, and reviewing trading information from our investment managers. In addition, we assess the inputs and methods used in determining the fair value in order to determine the classification of securities in the fair value hierarchy. The fair value of the currency derivatives are calculated from market spot rates, forward rates, interest rates, and credit ratings at the end of the period. Level 3: Unobservable inputs are used when little or no market data is available and reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. Securities In Gross Unrealized Loss Position. We periodically evaluate our investments for other-than- temporary declines in fair value. The unrealized losses on our AFS securities were primarily the result of unfavorable changes in interest rates subsequent to the initial purchase of these securities. The following table presents the gross unrealized losses and fair value for those AFS securities that were in an unrealized loss position for less than twelve months and for twelve months or greater as of July 1, 2022 and September 24, 2021 (in thousands): July 1, 2022 September 24, 2021 Less Than 12 Months 12 Months Or Greater Less Than 12 Months Investment Type Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Certificate of deposit $ 13,367 $ (32) $ — $ — $ 600 $ — U.S. agency securities 15,479 (29) 536 (20) 1,449 (2) Government bonds 72,788 (1,926) 3,300 (122) 8,940 (16) Commercial paper 17,580 (31) — — — — Corporate bonds 79,201 (1,440) 7,788 (206) 22,964 (25) Municipal debt securities 37,949 (420) 476 (24) 7,031 (9) Total $ 236,364 $ (3,878) $ 12,100 $ (372) $ 40,984 $ (52) As of September 24, 2021, there were no AFS securities that were in an unrealized loss position for twelve months or greater. Although we had certain securities that were in an unrealized loss position as of July 1, 2022 and September 24, 2021, we expect to recover the full carrying value of these securities. Investment Maturities. The following table summarizes the amortized cost and estimated fair value of the AFS securities within our investment portfolio based on stated maturities as of July 1, 2022 and September 24, 2021, which are recorded within cash equivalents and both short and long-term investments in our condensed consolidated balance sheets (in thousands): July 1, 2022 September 24, 2021 Range of maturity Amortized Cost Fair Value Amortized Cost Fair Value Due within 1 year $ 270,446 $ 269,123 $ 273,884 $ 274,037 Due in 1 to 2 years 61,673 60,081 40,739 40,874 Due in 2 to 5 years 38,911 37,652 15,506 15,490 Total $ 371,030 $ 366,856 $ 330,129 $ 330,401

Property, Plant and Equipment

Property, Plant and Equipment	9 Months Ended
	Jul. 01, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant, and Equipment PP&E are recorded at cost, with depreciation expense included in cost of licensing, cost of products and services, R&D, S&M, and G&A expenses in our condensed consolidated statements of operations. As of July 1, 2022 and September 24, 2021, PP&E consisted of the following (in thousands): Property, Plant, and Equipment July 1, September 24, Land $ 41,897 $ 42,041 Buildings and building improvements 286,104 284,146 Leasehold improvements 87,051 88,549 Machinery and equipment 136,763 128,008 Computer equipment and software 268,286 258,981 Furniture and fixtures 33,647 33,565 Equipment provided under operating leases 229,424 214,109 Construction-in-progress 18,193 22,923 Property, plant, and equipment, gross 1,101,365 1,072,322 Less: accumulated depreciation (583,495) (537,941) Property, plant, and equipment, net $ 517,870 $ 534,381

Leases

Leases	9 Months Ended
	Jul. 01, 2022
Leases [Abstract]
Leases	Leases As Lessee As a lessee, we enter into contracts to access and utilize office space, including those payable to our principal stockholder and portions attributable to the controlling interests in our consolidated subsidiaries. We determine if a contract contains a lease based on whether we have the right to obtain substantially all of the economic benefits from the use of an identified asset and whether we have the right to direct the use of an identified asset in exchange for consideration, which relates to an asset which we do not own. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. ROU assets are recognized as the lease liability, adjusted for lease incentives received. Lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value of the future lease payments is our IBR, because the interest rate implicit in our leases is not readily determinable. The IBR is a hypothetical rate based on our understanding of what our credit rating would be and resulting interest we would pay to borrow an amount equal to the lease payments in a similar economic environment over the lease term on a collateralized basis. Lease payments may be fixed or variable, however, only fixed payments are included in our lease liability calculation. Variable lease payments are recognized in operating expenses in the period in which the obligation for those payments is incurred. The lease term of operating leases vary from less than a year to 10 years. We have leases that include one or more options to extend the lease term for up to 5 years as well as options to terminate the lease within one year. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise such options. The components of lease expense were as follows (in thousands): Fiscal Quarter Ended Fiscal Year-To-Date Ended July 1, 2022 June 25, 2021 July 1, 2022 June 25, 2021 Lease cost Operating lease cost $ 4,177 $ 4,801 $ 13,335 $ 14,548 Variable lease cost 379 242 1,218 475 Total lease cost $ 4,556 $ 5,043 $ 14,553 $ 15,023 Supplemental cash flow information related to leases was as follows (in thousands): Fiscal Year-To Date Ended July 1, 2022 June 25, 2021 Other information Cash paid for amounts included in the measurement of operating lease liabilities $ 13,147 $ 14,366 Right-of-use assets obtained in exchange for operating lease obligations 1,459 5,013 Supplemental balance sheet information related to leases was as follows: July 1, 2022 September 24, 2021 Operating Leases Weighted-average remaining lease term 5.5 years 5.8 years Weighted-average discount rate 3.1 % 3.1 % The following table presents the maturity analysis of lease liabilities (in thousands): July 1, 2022 Operating Leases Remainder of Fiscal 2022 $ 4,266 Fiscal 2023 15,549 Fiscal 2024 13,122 Fiscal 2025 9,331 Fiscal 2026 5,778 Thereafter 16,378 Total undiscounted lease payments 64,424 Less: imputed interest (5,836) Total lease liabilities $ 58,588 As Lessor As a lessor, we lease our Dolby Cinema product solution to exhibitors and Dolby Voice equipment to cloud conferencing service providers. The terms of these leases vary from 4 to 10 years. Lease components consist of fixed payments and/or variable lease payments based on contracted percentages of revenue. Generally, leases do not grant any right to the lessee to purchase the underlying asset at the end of the lease term. Dolby Cinema lease arrangements have options to extend the lease term at expiration by increments ranging from 1 to 5 years. Assets provided under an operating lease are carried at cost within property, plant and equipment, net on the condensed consolidated balance sheets, and depreciated over the useful life of the asset using the straight-line method. Fixed operating lease payments are recognized on a straight-line basis over the lease term to revenue. Variable lease payments received under our Dolby Cinema operating leases are computed as shares of lessees' box office revenue and recognized to revenue in the period that box office sales occur. Lease incentive payments we make to lessees are amortized as a reduction in revenue over the lease term. The components of lease income were as follows (in millions): Fiscal Quarter Ended Fiscal Year-To-Date Ended July 1, 2022 June 25, 2021 July 1, 2022 June 25, 2021 Operating Lease Income Variable operating lease income $ 10.7 $ 2.7 $ 25.2 $ 3.5 Fixed operating lease income 0.7 1.0 2.3 3.2 If a lease is classified as a sales-type lease, the carrying amount of the asset is derecognized from property, plant and equipment, net, and a net investment in the lease is recorded. The net investment in the lease is measured at commencement date as the sum of the lease receivable and the estimated residual value of the equipment. The unguaranteed residual value of the equipment is determined as the estimated carrying value of the asset at the end of the lease term had the asset been depreciated on a straight-line basis. The unguaranteed residual value of sales-type leases as of July 1, 2022 and September 24, 2021 was not material. Selling profit or loss arising from a sales-type lease is recorded at lease commencement and presented on a gross basis. Over the term of the lease, we recognize interest income on the net investment in the lease, and variable lease payments, which are not included in the net investment in the lease. The variable lease payments are not material. The following table presents the maturity analysis of fixed lease payments due to Dolby (in thousands): July 1, 2022 Operating Leases Sales-Type Leases Remainder of Fiscal 2022 $ 26 $ 1,595 Fiscal 2023 774 1,595 Fiscal 2024 794 795 Fiscal 2025 815 395 Fiscal 2026 732 395 Thereafter — — Total undiscounted cash flows $ 3,141 4,775 Less: present value of lease payments (recognized as lease receivables) (4,333) Difference $ 442
Leases	Leases As Lessee As a lessee, we enter into contracts to access and utilize office space, including those payable to our principal stockholder and portions attributable to the controlling interests in our consolidated subsidiaries. We determine if a contract contains a lease based on whether we have the right to obtain substantially all of the economic benefits from the use of an identified asset and whether we have the right to direct the use of an identified asset in exchange for consideration, which relates to an asset which we do not own. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. ROU assets are recognized as the lease liability, adjusted for lease incentives received. Lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value of the future lease payments is our IBR, because the interest rate implicit in our leases is not readily determinable. The IBR is a hypothetical rate based on our understanding of what our credit rating would be and resulting interest we would pay to borrow an amount equal to the lease payments in a similar economic environment over the lease term on a collateralized basis. Lease payments may be fixed or variable, however, only fixed payments are included in our lease liability calculation. Variable lease payments are recognized in operating expenses in the period in which the obligation for those payments is incurred. The lease term of operating leases vary from less than a year to 10 years. We have leases that include one or more options to extend the lease term for up to 5 years as well as options to terminate the lease within one year. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise such options. The components of lease expense were as follows (in thousands): Fiscal Quarter Ended Fiscal Year-To-Date Ended July 1, 2022 June 25, 2021 July 1, 2022 June 25, 2021 Lease cost Operating lease cost $ 4,177 $ 4,801 $ 13,335 $ 14,548 Variable lease cost 379 242 1,218 475 Total lease cost $ 4,556 $ 5,043 $ 14,553 $ 15,023 Supplemental cash flow information related to leases was as follows (in thousands): Fiscal Year-To Date Ended July 1, 2022 June 25, 2021 Other information Cash paid for amounts included in the measurement of operating lease liabilities $ 13,147 $ 14,366 Right-of-use assets obtained in exchange for operating lease obligations 1,459 5,013 Supplemental balance sheet information related to leases was as follows: July 1, 2022 September 24, 2021 Operating Leases Weighted-average remaining lease term 5.5 years 5.8 years Weighted-average discount rate 3.1 % 3.1 % The following table presents the maturity analysis of lease liabilities (in thousands): July 1, 2022 Operating Leases Remainder of Fiscal 2022 $ 4,266 Fiscal 2023 15,549 Fiscal 2024 13,122 Fiscal 2025 9,331 Fiscal 2026 5,778 Thereafter 16,378 Total undiscounted lease payments 64,424 Less: imputed interest (5,836) Total lease liabilities $ 58,588 As Lessor As a lessor, we lease our Dolby Cinema product solution to exhibitors and Dolby Voice equipment to cloud conferencing service providers. The terms of these leases vary from 4 to 10 years. Lease components consist of fixed payments and/or variable lease payments based on contracted percentages of revenue. Generally, leases do not grant any right to the lessee to purchase the underlying asset at the end of the lease term. Dolby Cinema lease arrangements have options to extend the lease term at expiration by increments ranging from 1 to 5 years. Assets provided under an operating lease are carried at cost within property, plant and equipment, net on the condensed consolidated balance sheets, and depreciated over the useful life of the asset using the straight-line method. Fixed operating lease payments are recognized on a straight-line basis over the lease term to revenue. Variable lease payments received under our Dolby Cinema operating leases are computed as shares of lessees' box office revenue and recognized to revenue in the period that box office sales occur. Lease incentive payments we make to lessees are amortized as a reduction in revenue over the lease term. The components of lease income were as follows (in millions): Fiscal Quarter Ended Fiscal Year-To-Date Ended July 1, 2022 June 25, 2021 July 1, 2022 June 25, 2021 Operating Lease Income Variable operating lease income $ 10.7 $ 2.7 $ 25.2 $ 3.5 Fixed operating lease income 0.7 1.0 2.3 3.2 If a lease is classified as a sales-type lease, the carrying amount of the asset is derecognized from property, plant and equipment, net, and a net investment in the lease is recorded. The net investment in the lease is measured at commencement date as the sum of the lease receivable and the estimated residual value of the equipment. The unguaranteed residual value of the equipment is determined as the estimated carrying value of the asset at the end of the lease term had the asset been depreciated on a straight-line basis. The unguaranteed residual value of sales-type leases as of July 1, 2022 and September 24, 2021 was not material. Selling profit or loss arising from a sales-type lease is recorded at lease commencement and presented on a gross basis. Over the term of the lease, we recognize interest income on the net investment in the lease, and variable lease payments, which are not included in the net investment in the lease. The variable lease payments are not material. The following table presents the maturity analysis of fixed lease payments due to Dolby (in thousands): July 1, 2022 Operating Leases Sales-Type Leases Remainder of Fiscal 2022 $ 26 $ 1,595 Fiscal 2023 774 1,595 Fiscal 2024 794 795 Fiscal 2025 815 395 Fiscal 2026 732 395 Thereafter — — Total undiscounted cash flows $ 3,141 4,775 Less: present value of lease payments (recognized as lease receivables) (4,333) Difference $ 442

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Jul. 01, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill The following table outlines changes to the carrying amount of goodwill (in thousands): Goodwill Balance at September 24, 2021 $ 340,694 Acquired goodwill (1) 31,638 Translation adjustments (4,050) Balance at July 1, 2022 $ 368,282 (1) Refer to Note 16 " Business Combination " for additional information related to our acquired goodwill. Intangible Assets Our intangible assets are stated at their original cost less accumulated amortization, and principally consist of acquired patents, technology, customer relationships and contracts, and trademarks. Intangible assets subject to amortization consisted of the following (in thousands): July 1, 2022 September 24, 2021 Intangible Assets Cost Accumulated Net Cost Accumulated Net Acquired patents and technology $ 361,497 $ (252,896) $ 108,601 $ 343,280 $ (233,789) $ 109,491 Customer relationships 66,178 (55,717) 10,461 65,822 (52,730) 13,092 Other intangible assets 23,012 (22,823) 189 22,972 (22,665) 307 Total $ 450,687 $ (331,436) $ 119,251 $ 432,074 $ (309,184) $ 122,890 During the fiscal year-to-date period ended July 1, 2022, we purchased various patents for purchase consideration of $11.5 million and upon acquisition, these intangible assets had a weighted-average useful life of 16.0 years. These intangible assets facilitate our R&D efforts, technologies, and potential product offerings. We also acquired various identifiable intangible assets, which primarily consisted of developed technology, as a part of the business combination completed during the second quarter of fiscal 2022. Refer to Note 16, " Business Combination " for additional information on this transaction. Amortization expense for our intangible assets is included in cost of licensing, cost of products and services, R&D, S&M, and G&A expenses in our condensed consolidated statements of operations. Amortization expense was $6.6 million and $7.3 million in the third quarter of fiscal 2022 and 2021, respectively, and $22.2 million and $21.9 million in the fiscal year-to-date period ended July 1, 2022 and June 25, 2021, respectively. As of July 1, 2022, expected amortization expense of our intangible assets in future fiscal periods was as follows (in thousands): Fiscal Year Amortization Expense Remainder of 2022 $ 7,045 2023 26,083 2024 23,954 2025 8,884 2026 7,993 Thereafter 45,292 Total $ 119,251

Stockholders' Equity And Stock-

Stockholders' Equity And Stock-Based Compensation	9 Months Ended
	Jul. 01, 2022
Stockholders' Equity And Stock-Based Compensation [Abstract]
Stockholders' Equity And Stock-Based Compensation	Stockholders' Equity and Stock-Based Compensation We provide stock-based awards as a form of compensation for employees, officers, and directors. We issue stock-based awards in the form of stock options and RSUs under our equity incentive plans, as well as shares under our ESPP. Common Stock - Class A and Class B Our Board of Directors has authorized two classes of common stock, Class A and Class B. As of July 1, 2022, we had authorized 500,000,000 Class A shares and 500,000,000 Class B shares. As of July 1, 2022, we had 62,578,760 shares of Class A common stock and 36,086,629 shares of Class B common stock issued and outstanding. Holders of our Class A and Class B common stock have identical rights, except that holders of our Class A common stock are entitled to one vote per share and holders of our Class B common stock are entitled to ten votes per share. Shares of Class B common stock can be converted to shares of Class A common stock at any time at the option of the stockholder and automatically convert upon sale or transfer, except for certain transfers specified in our amended and restated certificate of incorporation. Stock Incentive Plans Following shareholder approval in January 2005, our 2005 Stock Plan was adopted by our Board of Directors on February 16, 2005. In February 2020, our stockholders approved the name change of our 2005 Stock Plan to the 2020 Stock Plan and certain other changes described in our proxy statement for our 2020 annual meeting of stockholders. Our 2020 Stock Plan, as amended and restated, provides for the ability to grant incentive stock options, non-qualified stock options, restricted stock, RSUs, stock appreciation rights, deferred stock units, performance units, performance bonus awards, and performance shares. A total of 55.0 million shares of our Class A common stock have been authorized for issuance under the 2020 Stock Plan in total since inception of the plan. For awards granted prior to February 2011, any shares subject to an award with a per share price less than the fair market value of our Class A common stock on the date of grant and any shares subject to an outstanding RSU award will be counted against the authorized share reserve as two shares for every one share subject to the award, and if returned to the 2020 Stock Plan, such shares will be counted as two shares for every one share returned. For those awards granted from February 2011 onward, any shares subject to an award with a per share price less than the fair market value of our Class A common stock on the date of grant and any shares subject to an outstanding RSU award will be counted against the authorized share reserve as 1.6 shares for every one share subject to the award, and if returned to the 2020 Stock Plan, such shares will be counted as 1.6 shares for every one share returned. Stock Options. Stock options are granted at fair market value on the date of grant. Options granted to employees and officers generally vest over four years, with 25% of the shares subject to the option becoming exercisable on the one-year anniversary of the date of grant and the balance of the shares vesting in equal monthly installments over the following 36 months. These options expire on the earlier of ten years after the date of grant or three months after termination of service. All options granted vest over the requisite service period and upon the exercise of stock options, we issue new shares of Class A common stock under the 2020 Stock Plan. Our 2020 Stock Plan also allows us to grant stock awards which vest based on the satisfaction of specific performance criteria. Performance-Based Stock Options. In fiscal 2016, we began granting PSOs to our executive officers with shares of our Class A common stock underlying such options. The contractual term for the PSOs is seven years, with vesting contingent upon market-based performance conditions, representing the achievement of specified Dolby annualized TSR targets at the end of a three-year measurement period following the date of grant. If the minimum conditions are met, the PSOs earned will cliff vest on the third anniversary of the grant date, upon certification of achievement of the performance conditions by our Compensation Committee. Anywhere from 0% to 125% of the shares subject to a PSO may vest based on achievement of the performance conditions at the end of the three-year performance period. The value of the PSOs, which is recognized as compensation cost, is calculated using a Monte Carlo valuation model. Aside from the use of an expected term for the PSOs commensurate with their shorter contractual term, the nature of the valuation inputs used in the Monte Carlo valuation model were consistent with those used to value our non-performance based options granted under the 2020 Stock Plan. Compensation cost is being amortized on a straight-line basis over the requisite service period. The following table summarizes information about PSOs granted to our executive officers that have vested: Grant Date Aggregate Shares Granted at Target Award Aggregate Shares Exercisable at Vest Date (1) Percentage Vested of Target Award Vested Date December 15, 2015 419,623 334,623 125 % December 2018 December 15, 2016 276,199 240,539 95 % December 2019 December 15, 2017 264,000 253,440 96 % December 2020 December 15, 2018 241,100 158,700 75 % December 2021 (1) Aggregate shares exercisable at vest date does not include any shares that were cancelled before the vest date after they were granted. As of July 1, 2022, an aggregate of 424,249 shares of PSOs were exercisable and outstanding. The following table summarizes information about stock options, including PSOs, issued under our 2020 Stock Plan: Shares Weighted-Average Weighted-Average Aggregate Intrinsic Value (1) (in thousands) (in years) (in thousands) Options outstanding at September 25, 2021 4,577 $ 59.18 Grants 369 88.37 Exercises (685) 52.97 Forfeitures and cancellations (121) 73.58 Options outstanding at July 1, 2022 4,140 62.38 5.62 $ 47,767 Options vested and expected to vest at July 1, 2022 3,974 61.82 5.54 47,724 Options exercisable at July 1, 2022 3,033 56.26 4.68 46,015 (1) Aggregate intrinsic value is based on the closing stock price of our Class A common stock on July 1, 2022 of $70.82 and excludes the impact of options that were not in-the-money. Restricted Stock Units. Beginning in fiscal 2008, we began granting RSUs to certain directors, officers and employees. Awards granted to employees and officers generally vest over four years, with equal annual cliff-vesting. Awards granted from November 2010 onward to ongoing directors generally vest over approximately one year. Awards granted to new directors from fiscal 2014 onward vest on the earlier of the first anniversary of the award’s date of grant, or the day immediately preceding the date of the next annual meeting of stockholders that occurs after the award’s date of grant. At each vesting date, the holder of the award is issued shares of our Class A common stock. Compensation expense from these awards is equal to the adjusted fair market value of our Class A common stock on the date of grant, discounted to account for dividend payments forgone during the vesting period, and is recognized on a straight-line basis over the requisite service period. Certain grants may have other vesting conditions or other award terms as approved by the Compensation Committee of our Board of Directors. Our 2020 Stock Plan also allows us to grant RSUs that vest based on the satisfaction of specific performance criteria. Performance-Based Restricted Stock Units. In the first quarter of fiscal 2020, we began granting PSUs to our executive officers with shares of our Class A common stock underlying such awards. The terms of the PSU Agreement adopted in the first quarter fiscal 2020 provide for the grant of PSUs to our executive officers contingent on Dolby's achievement of annualized TSR targets measured against a comparator index over a three-year performance period following the date of grant. Anywhere from 0% to 200% of eligible restricted stock units may vest based on achievement of the performance conditions at the end of the three-year performance period. The value of the PSUs, which is recognized as compensation cost, is calculated using a Monte Carlo valuation model. Compensation cost is being amortized on a straight-line basis over the requisite service period. Certain grants may have other vesting conditions or other award terms as approved by the Compensation Committee of our Board of Directors. On December 15, 2021, we granted PSUs to our executive officers vesting for an aggregate of 60,301 shares at the target award amount, which would vest at 120,602 shares at 200% of the target award amount. On December 15, 2020, we granted PSUs to our executive officers vesting for an aggregate of 66,138 shares at the target award amount, which would vest at 132,276 shares at 200% of the target award amount. On December 16, 2019, we granted PSUs to our executive officers vesting for an aggregate of 62,000 shares at the target award amount, which would vest at 124,000 shares at 200% of the target award amount. As of July 1, 2022, PSUs that would vest for an aggregate of 162,846 shares at the target award amount (325,692 shares at 200% of the target award amount) were outstanding. The following table summarizes information about RSUs, including PSUs, issued under our 2020 Stock Plan: Shares Weighted-Average (in thousands) Non-vested at September 24, 2021 3,335 $ 77.46 Granted 1,673 86.93 Vested (1,107) 71.80 Forfeitures (291) 80.27 Non-vested at July 1, 2022 3,610 $ 83.36 Employee Stock Purchase Plan . Our plan allows eligible employees to have up to 10 percent of their eligible compensation withheld and used to purchase Class A common stock, subject to a maximum of $25,000 worth of stock purchased in a calendar year or no more than 1,000 shares in an offering period, whichever is less. An offering period consists of successive six-month purchase periods, with a look back feature to our stock price at the commencement of a one-year offering period. The plan provides for a discount equal to 15 percent of the lower of the closing price of our Class A common stock on the New York Stock Exchange on the first and last day of the offering periods. The plan also includes an automatic reset feature that provides for an offering period to be reset and recommenced to a new lower-priced offering if the offering price of a new offering period is less than that of the immediately preceding offering period. Stock Option Valuation Assumptions We use the Black-Scholes option pricing model to determine the estimated fair value of employee stock options at the date of the grant. The Black-Scholes model includes inputs that require us to make certain estimates and assumptions regarding the expected term of the award, as well as the future risk-free interest rate, and the volatility of our stock price over the expected term of the award. Expected Term. The expected term of an award represents the estimated period of time that options granted will remain outstanding, and is measured from the grant date to the date at which the option is either exercised or canceled. Our determination of the expected term involves an evaluation of historical terms and other factors such as the exercise and termination patterns of our employees who hold options to acquire our Class A common stock, and is based on certain assumptions made regarding the future exercise and termination behavior. Risk-Free Interest Rate. The risk-free interest rate is based on the yield curve of U.S. Treasury instruments in effect on the date of grant. In determining an estimate for the risk-free interest rate, we use average interest rates based on these instruments’ constant maturities with a term that approximates and corresponds with the expected term of our awards. Expected Stock Price Volatility. The expected volatility represents the estimated volatility in the price of our Class A common stock over a time period that approximates the expected term of the awards, and is determined using a blended combination of historical and implied volatility. Historical volatility is representative of the historical trends in our stock price for periods preceding the measurement date for a period that is commensurate with the expected term. Implied volatility is based upon externally traded option contracts of our Class A common stock. Dividend Yield. The dividend yield is based on our anticipated dividend payout over the expected term of our option awards. Dividend declarations and the establishment of future record and payment dates are subject to the Board of Directors’ continuing determination that the dividend policy is in the best interests of our stockholders. The dividend policy may be changed or canceled at the discretion of the Board of Directors at any time. The weighted-average assumptions used in the determination of the fair value of our stock options were as follows: Fiscal Quarter Ended Fiscal Year-To-Date Ended July 1, July 1, June 25, Expected term (in years) 4.78 4.78 4.88 Risk-free interest rate 3.0 % 1.5 % 0.4 % Expected stock price volatility 29.7 % 28.8 % 28.7 % Dividend yield 1.3 % 1.1 % 1.1 % There were no stock options granted during the third quarter of fiscal 2021. Stock-Based Compensation Expense Stock-based compensation expense for equity awards granted to employees is determined by estimating their fair value on the date of grant, and recognizing that value as an expense on a straight-line basis over the requisite service period in which our employees earn the awards. Compensation expense related to these equity awards is recognized net of estimated forfeitures, which reduce the expense recorded in the condensed consolidated statements of operations. The selection of applicable estimated forfeiture rates is based on an evaluation of trends in our historical forfeiture data with consideration for other potential driving factors. If in subsequent periods actual forfeitures significantly differ from our initial estimates, we will revise such estimates accordingly. The following two tables separately present stock-based compensation expense both by award type and classification in our condensed consolidated statements of operations (in thousands): Expense - By Award Type Fiscal Quarter Ended Fiscal Year-To-Date Ended July 1, June 25, July 1, June 25, Compensation expense Stock options $ 2,321 $ 3,203 $ 7,939 $ 10,913 Restricted stock units (1) 23,715 20,348 75,121 60,594 Employee stock purchase plan 1,572 1,285 4,903 4,055 Total stock-based compensation 27,608 24,836 87,963 75,562 Estimated benefit from income taxes (4,280) (3,944) (13,811) (12,015) Total stock-based compensation, net of tax $ 23,328 $ 20,892 $ 74,152 $ 63,547 (1) Stock-based compensation expense incurred by restricted stock units includes expense from PSUs. Expense - By Income Statement Line Item Classification Fiscal Quarter Ended Fiscal Year-To-Date Ended July 1, June 25, July 1, June 25, Compensation expense Cost of products and services $ 415 $ 426 $ 1,407 $ 1,549 Research and development 9,171 7,296 28,428 22,419 Sales and marketing 9,718 9,286 31,757 28,192 General and administrative 8,304 7,828 26,371 23,402 Total stock-based compensation expense 27,608 24,836 87,963 75,562 Estimated benefit from income taxes (4,280) (3,944) (13,811) (12,015) Total stock-based compensation, net of tax $ 23,328 $ 20,892 $ 74,152 $ 63,547 The tax benefit that we recognize from shares issued under our ESPP is excluded from the tables above. The tax benefit recognized was not material in the third quarter of fiscal 2022 and fiscal 2021, or in the fiscal year-to-date period ended July 1, 2022 and June 25, 2021. Unrecognized Compensation Expense. As of July 1, 2022, total unrecognized compensation expense associated with employee stock options expected to vest was approximately $15.3 million, which is expected to be recognized over a weighted-average period of 2.4 years. As of July 1, 2022, total unrecognized compensation expense associated with RSUs expected to vest was approximately $211.5 million, which is expected to be recognized over a weighted-average period of 2.6 years. Common Stock Repurchase Program In November 2009, we announced a stock repurchase program ("program"), providing for the repurchase of our Class A common stock. The following table summarizes the initial amount of authorized repurchases as well as additional repurchases approved by our Board of Directors as of July 1, 2022 (in thousands): Authorization Period Authorization Amount Fiscal 2010: November 2009 $ 250,000 Fiscal 2010: July 2010 300,000 Fiscal 2011: July 2011 250,000 Fiscal 2012: February 2012 100,000 Fiscal 2015: October 2014 200,000 Fiscal 2017: January 2017 200,000 Fiscal 2018: July 2018 350,000 Fiscal 2019: July 2019 350,000 Fiscal 2021: July 2021 350,000 Fiscal 2022: February 2022 250,000 Total $ 2,600,000 Stock repurchases under the program may be made through open market transactions, negotiated purchases, or otherwise, at times and in amounts that we consider appropriate. The timing of repurchases and the number of shares repurchased depend upon a variety of factors, including price, regulatory requirements, the rate of dilution from our equity compensation plans, and other market conditions. The program does not have a specified expiration date, and can be limited, suspended, or terminated at our discretion at any time without prior notice. Shares repurchased under the program will be returned to the status of authorized but unissued shares of Class A common stock. As of July 1, 2022, the remaining authorization to purchase additional shares was approximately $230.9 million. The following table provides information regarding share repurchase activity under the program during fiscal 2022: Quarterly Repurchase Activity Shares Cost (1) Average Price Paid Per Share (2) (in thousands) Q1 - Quarter ended December 31, 2021 408,508 $ 35,573 $ 87.08 Q2 - Quarter ended April 1, 2022 1,116,032 84,913 76.08 Q3 - Quarter ended July 1, 2022 2,549,474 190,000 74.53 Total 4,074,014 $ 310,486 (1) Cost of share repurchases includes the price paid per share, and excludes commission costs. (2) Average price paid per share excludes commission costs. Dividend Program The following table summarizes dividends declared under the program during fiscal 2022: Fiscal Period Announcement Date Record Date Payment Date Cash Dividend Per Common Share Dividend Payment Q1 - Quarter ended December 31, 2021 February 3, 2022 February 16, 2022 February 23, 2022 $ 0.25 $25.3 million Q2 - Quarter ended April 1, 2022 May 5, 2022 May 17, 2022 May 25, 2022 $ 0.25 $25.1 million Q3 - Quarter ended July 1, 2022 August 9, 2022 August 23, 2022 August 31, 2022 $ 0.25 $24.7 million (1) (1) The dividend payment amount for the dividend declared in the third quarter of fiscal 2022 is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	9 Months Ended
	Jul. 01, 2022
Equity [Abstract]
Accumulated Other Comprehensive Income	Accumulated Other Comprehensive Loss Other comprehensive income/loss consists of three components: unrealized gains or losses on our AFS marketable investment securities, gains and losses on derivatives in cash flow hedge relationships not yet recognized in earnings, and the gains and losses from the translation of assets and liabilities denominated in non-U.S. dollar functional currencies. Until realized and reported as a component of net income, these comprehensive income items accumulate and are included within accumulated other comprehensive loss, a subsection within stockholders’ equity in our condensed consolidated balance sheets. Unrealized gains and losses on our investment securities are reclassified from AOCI into earnings when realized upon sale and are determined based on specific identification of securities sold. Unrealized gains and losses on our cash flow hedges are reclassified from AOCI into earnings when the hedged operating expenses are recognized, which is also when the gains and losses are realized. The following table summarizes the changes in the accumulated balances during the period, and includes information regarding the manner in which the reclassifications out of AOCI into earnings affect our condensed consolidated statements of operations (in thousands): Fiscal Quarter Ended Fiscal Year-To-Date Ended Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Beginning Balance $ (3,800) $ 56 $ (11,937) $ (15,681) $ 220 $ (122) $ (10,128) $ (10,030) Other comprehensive loss before reclassifications: Unrealized losses (414) (362) — (776) (4,971) (6) — (4,977) Foreign currency translation losses (1) — — (13,821) (13,821) — — (15,630) (15,630) Income tax effect - benefit — 97 — 97 — — — — Net of tax (414) (265) (13,821) (14,500) (4,971) (6) (15,630) (20,607) Amounts reclassified from AOCI into earnings: Realized gains/(losses) (2) (15) (314) — (329) 527 (412) — 115 Income tax effect - benefit/(expense) (3) 3 81 — 84 (2) 98 — 96 Net of tax (12) (233) — (245) 525 (314) — 211 Net current-period other comprehensive loss (426) (498) (13,821) (14,745) (4,446) (320) (15,630) (20,396) Ending Balance $ (4,226) $ (442) $ (25,758) $ (30,426) $ (4,226) $ (442) $ (25,758) $ (30,426) Fiscal Quarter Ended Fiscal Year-To-Date Ended Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Beginning Balance $ 458 $ 3,751 $ (8,248) $ (4,039) $ 818 $ 3,969 $ (15,381) $ (10,594) Other comprehensive income/(loss) before reclassifications: Unrealized losses (212) (4,293) — (4,505) (819) (8,203) — (9,022) Foreign currency translation gains — — 937 937 — — 8,577 8,577 Income tax effect - benefit/(expense) 44 115 (110) 49 100 180 (617) (337) Net of tax (168) (4,178) 827 (3,519) (719) (8,023) 7,960 (782) Amounts reclassified from AOCI into earnings: Realized gains (2) 8 2,758 — 2,766 209 6,780 — 6,989 Income tax effect - expense (3) (2) (238) — (240) (12) (633) — (645) Net of tax 6 2,520 — 2,526 197 6,147 — 6,344 Net current-period other comprehensive income/(loss) (162) (1,658) 827 (993) (522) (1,876) 7,960 5,562 Ending Balance $ 296 $ 2,093 $ (7,421) $ (5,032) $ 296 $ 2,093 $ (7,421) $ (5,032) (1) The foreign currency translation losses during the third quarter of fiscal 2022 and the fiscal year-to-date period ended July 1, 2022 were primarily due the strengthening of the U.S. dollar compared to other foreign currencies. (2) Realized gains or losses, if any, from the sale of our AFS investment securities or from foreign currency translation adjustments are included within other income/(expense), net in our condensed consolidated statements of operations. Realized gains or losses on foreign currency contracts designated as cash flow hedges are included in operating expenses in the condensed consolidated statements of operations. (3) The income tax benefit or expense is included within provision for income taxes in our condensed consolidated statements of operations.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Jul. 01, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic EPS is computed by dividing net income attributable to Dolby Laboratories, Inc. by the number of weighted-average shares of Class A and Class B common stock outstanding during the period. Through application of the treasury stock method, diluted EPS is computed in the same manner, except that the number of weighted-average shares outstanding is increased by the number of potentially dilutive shares from employee incentive plans during the period. Basic and diluted EPS are computed independently for each fiscal quarter and year-to-date period, which involves the use of different weighted-average share count figures relating to quarterly and annual periods. As a result, and after factoring the effect of rounding to the nearest cent per share, the sum of all four quarter-to-date EPS figures may not equal year-to-date EPS. Potentially dilutive shares represent the hypothetical number of incremental shares issuable under the assumed exercise of outstanding stock options (both vested and non-vested) and vesting of outstanding RSUs. The calculation of dilutive shares outstanding excludes securities that would have an antidilutive effect on EPS. The following table sets forth the computation of basic and diluted EPS attributable to Dolby Laboratories, Inc. (in thousands, except per share amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended July 1, June 25, July 1, June 25, Numerator: Net income attributable to Dolby Laboratories, Inc. $ 39,597 $ 54,621 $ 156,331 $ 266,036 Denominator: Weighted-average shares outstanding—basic 100,213 101,351 100,936 101,177 Potential common shares from options to purchase common stock 779 2,062 1,037 2,033 Potential common shares from restricted stock units 409 1,169 916 1,319 Potential common shares from employee stock purchase plan 73 51 104 78 Weighted-average shares outstanding—diluted 101,474 104,633 102,993 104,607 Net income per share attributable to Dolby Laboratories, Inc.: Basic $ 0.40 $ 0.54 $ 1.55 $ 2.63 Diluted $ 0.39 $ 0.52 $ 1.52 $ 2.54 Antidilutive awards excluded from calculation: Stock options 756 283 552 200 Restricted stock units 2,304 — 1,088 12 Employee stock purchase plan — 1 — 2

Income Taxes

Income Taxes	9 Months Ended
	Jul. 01, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our income tax expense, deferred tax assets and liabilities, and unrecognized tax benefits reflect management's best assessment of estimated current and future liabilities. We are subject to income taxes in the U.S. and numerous foreign jurisdictions. Significant judgments and estimates are required in determining the consolidated income tax expense. Unrecognized Tax Benefits As of July 1, 2022, the total amount of gross unrecognized tax benefits was $68.1 million, of which $47.8 million, if recognized, would reduce our effective tax rate. As of September 24, 2021, the total amount of gross unrecognized tax benefits was $66.1 million, of which $43.6 million, if recognized, would reduce our effective tax rate. The year-to-date period ended July 1, 2022 increase was primarily due to current year reserves for transfer pricing, withholding taxes, and interest accruals partially offset by reserve releases due to audit settlement. Our liability for unrecognized tax benefits is classified within other non-current liabilities in our condensed consolidated balance sheets. Effective Tax Rate Each period, the combination of multiple different factors can impact our effective tax rate. These factors include both recurring items such as tax rates and the relative amount of income earned in foreign jurisdictions, as well as discrete items that may occur in, but are not necessarily consistent between periods. Our effective tax rate in the third quarter of fiscal 2022 was 19.8% or a tax expense of $9.8 million and our effective tax rate in the third quarter of fiscal 2021 was 7.7% or a tax expense of $4.6 million. The increase in our effective tax rate was primarily due to a shift in the mix of earnings to jurisdictions with higher tax rates and lower tax benefits related to settlement of stock-based awards partially offset by benefit from the settlement of Federal tax audit. Our effective tax rate in the third quarter of fiscal 2022 year-to-date period was 15.3% or a tax expense of $28.2 million and our effective tax rate in the third quarter of fiscal 2021 year-to-date period was 12.2% or a tax expense of $37.9 million. The increase in our effective tax rate was primarily due to a shift in the mix of earnings to jurisdictions with higher tax rates and lower tax benefits related to settlement of stock-based awards. Compared to the Federal statutory rate of 21%, our effective tax rates for the third quarter of fiscal 2022 and year-to-date period ended July 1, 2022 were lower primarily due to the mix of earnings favoring jurisdictions with lower tax rates and tax benefits related to stock-based compensation.

Restructuring

Restructuring	9 Months Ended
	Jul. 01, 2022
Restructuring Charges [Abstract]
Restructuring	Restructuring Restructuring charges recorded in our condensed consolidated statements of operations represent costs associated with separate individual restructuring plans implemented in various fiscal periods. Costs arising from these actions, including fluctuations in related balances between fiscal periods, are based on the nature of activities under the various plans. Fiscal 2022 Restructuring Events. In January 2022, we implemented a restructuring plan within our entertainment organization to create capacity to support our higher priority focus areas. As a result, we recorded $4.3 million in restructuring costs in the fiscal year-to-date period ended July 1, 2022, primarily representing severance and other related benefits offered to over 50 employees that were impacted by this action. Actions related to this plan are expected to be completed by the end of fiscal 2022. The table presented below summarizes the changes in our restructuring accruals (in thousands): Severance Leased facility exit costs and other costs Total Balance at September 25, 2020 $ — $ — $ — Restructuring charges 9,522 718 10,240 Cash payments and adjustments (9,359) (714) (10,073) Balance at September 24, 2021 $ 163 $ 4 $ 167 Restructuring charges 4,336 1,707 6,043 Cash payments and adjustments (3,256) (1,711) (4,967) Balance at July 1, 2022 $ 1,243 $ — $ 1,243

Legal Matters

Legal Matters	9 Months Ended
	Jul. 01, 2022
Loss Contingency, Information about Litigation Matters [Abstract]
Legal Matters	Legal Matters We are involved in various legal proceedings that occasionally arise in the normal course of business. These can include claims of alleged infringement of IP rights, commercial, employment, and other matters. In our opinion, resolution of these proceedings is not expected to have a material adverse impact on our operating results or financial condition. On a quarterly basis, we evaluate based on the known facts and circumstances whether a potential loss or range of losses is considered probable and reasonably estimable in accordance with U.S. GAAP. We record a provision for a liability relating to these legal proceedings when a loss is both probable and the amount of the loss can be reasonably estimated. Legal costs associated with these legal proceedings are expensed as incurred. Given the unpredictable nature of legal proceedings, it is possible that an unfavorable resolution of one or more such proceedings could materially affect our future operating results or financial condition in a particular period, including as a result of required changes to our licensing terms, monetary penalties, and other potential consequences. However, based on the information known by us as of the date of this filing and the rules and regulations applicable to the preparation of our condensed consolidated financial statements, other than the impact of the litigation matter discussed in Note 15, any such amounts are either immaterial, or it is not probable that a potential loss has been incurred or the amount of loss cannot be reasonably estimated.

Commitments And Contingencies

Commitments And Contingencies	9 Months Ended
	Jul. 01, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments And Contingencies	Commitments and Contingencies In the ordinary course of business, we enter into contractual agreements with third parties that include non-cancelable payment obligations, for which we are liable in future periods. These arrangements can include terms binding us to minimum payments and/or penalties if we terminate the agreement for any reason other than an event of default as described by the agreement. The following table presents a summary of our contractual obligations and commitments as of July 1, 2022 (in thousands): Payments Due By Fiscal Period Remainder of Fiscal 2022 Fiscal Fiscal Fiscal Fiscal Thereafter Total Naming rights $ 2,075 $ 12,474 $ 12,794 $ 13,126 $ 13,472 $ 52,850 $ 106,791 Purchase obligations 8,649 27,455 4,809 512 — — 41,425 Donation commitments 1,651 196 116 116 116 503 2,698 Total $ 12,375 $ 40,125 $ 17,719 $ 13,754 $ 13,588 $ 53,353 $ 150,914 Naming Rights. We have entered into agreements for naming rights of certain facilities, most significantly for naming rights and related benefits with respect to the Dolby Theatre in Hollywood, California, the location of the Academy Awards®. The term of this agreement is 20 years, over which we will make payments on a semi-annual basis until fiscal 2032. Our ongoing annual payment obligations are conditioned in part on the Academy Awards being held and broadcast from the Dolby Theatre. Our payment obligations may be suspended or reduced in certain circumstances, including the protracted closure of the Dolby Theatre. Purchase Obligations. Purchase obligations primarily consist of our commitments made under agreements to purchase goods and services related to Dolby Cinema and for purposes that include information technology and telecommunications, marketing and professional services, and manufacturing and other R&D activities. Donation Commitments. Our donation commitments relate to non-cancelable obligations that consist of maintenance services and installation of imaging and audio products in exchange for various marketing, branding, and publicity benefits. These donation agreements either transfer title of our audio and imaging products to the donee or offer use of the products free of charge for a specified period of time via a leasing arrangement. The recipients of these donations participate in or promote the cinema and entertainment industry, and our commitments vary in length, lasting up to 15 years. Indemnification Clauses. On a limited basis, our contractual agreements contain a clause under which we agree to provide indemnification to the counterparty, most commonly to licensees in connection with licensing arrangements that include our IP. We have also entered into indemnification agreements with our officers, directors, and certain employees, and our certificate of incorporation and bylaws contain similar indemnification obligations. Additionally, and although not a contractual requirement, we have at times elected to defend our licensees from third party IP infringement claims. Since the terms and conditions of our contractual indemnification clauses do not explicitly specify our obligations, we are unable to reasonably estimate the maximum potential exposure for which we could be liable.

Subsequent Event

Subsequent Event	9 Months Ended
	Jul. 01, 2022
Subsequent Events [Abstract]
Subsequent Event	Subsequent Event Share Repurchase Program . On August 9, 2022, we announced that our Board of Directors approved increasing the size of our stock repurchase program by $350 million, bringing the amount available for future repurchases of our Class A Common Stock to approximately $581 million. Stock repurchases under this program may be made through open market transactions, negotiated purchases, or otherwise, at times and in amounts that we consider appropriate. The timing of repurchases and the number of shares repurchased depend upon a variety of factors, including price, regulatory requirements, the rate of dilution from our equity compensation plans, and other market conditions. The program does not have a specified expiration date, and can be limited, suspended or terminated at our discretion at any time without prior notice. Shares repurchased under the program will be returned to the status of authorized but unissued shares of Class A common stock.

Business Combinations

Business Combinations	9 Months Ended
	Jul. 01, 2022
Business Combinations [Abstract]
Business Combinations	Business Combination Millicast, Inc. On January 31, 2022, we completed our acquisition of all outstanding interests of Millicast, Inc. ("Millicast"), a privately held company. Following the acquisition, Millicast is expected to enable developers to take the interactive events they build with Dolby.io, and stream them from the presenter to large audiences. We have included the financial results of Millicast in our condensed consolidated financial statements from the date of acquisition, and these results were not material. Additionally, the transaction costs associated with the acquisition were not material. The total purchase consideration of the acquisition was $38.8 million. We allocated $8.7 million in purchase consideration to identifiable intangible assets, which primarily consisted of developed technology, with estimated useful lives of 1.5 years to 8 years. We also recorded $31.7 million of goodwill, which is representative of our expectation of benefits and synergies from the integration of Millicast technology with our existing technology and the assembled workforce of Millicast. The fair values assigned to assets acquired and liabilities assumed are based on management’s estimates and assumptions and may be subject to change as additional information is received and certain tax returns are finalized. We expect to finalize the valuation within the one year measurement period.

Summary Of Significant Accoun_2

Summary Of Significant Accounting Policies (Policy)	9 Months Ended
	Jul. 01, 2022
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The unaudited interim condensed consolidated financial statements include the accounts of Dolby Laboratories, Inc. and our wholly owned subsidiaries. In addition, we have consolidated the financial results of jointly owned affiliated companies in which our principal stockholder has a controlling interest. We report these controlling interests as a separate line in our condensed consolidated statements of operations as net income attributable to controlling interest and in our condensed consolidated balance sheets as a controlling interest. We eliminate all intercompany accounts and transactions upon consolidation.
Operating Segments	Operating Segments Since we operate as a single reportable segment, all required financial segment information is included in our unaudited interim condensed consolidated financial statements. This reflects the fact that our CODM, our CEO, evaluates our financial information and resources, and assesses the performance of these resources on a consolidated basis.
Use of Estimates	Use of Estimates The preparation of our financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts reported and disclosed in our unaudited interim condensed consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include estimated shipments by our licensees for which we are owed a sales-based royalty. These estimates involve the use of historical data and judgment for several key attributes including industry estimates of expected shipments, the percentage of markets using our technologies, and average sale prices. Our estimates of royalty-based revenue also take into consideration the macroeconomic effect of global events, such as the coronavirus pandemic ("COVID-19") or other natural disasters which may impact our licensees' supply chain activities as well as demand for shipments. Additional significant items subject to such estimates and assumptions include ESPs for performance obligations within revenue arrangements; allowances for credit losses for accounts receivable; carrying values of inventories and certain PP&E, goodwill and intangible assets; fair values of investments; accrued liabilities including unrecognized tax benefits, deferred income tax assets and liabilities, and contingent liabilities; and stock-based compensation. Actual results could differ from our estimates.
Fiscal Year	Fiscal YearOur fiscal year is a 52 or 53 week period ending on the last Friday in September. The fiscal periods presented herein include the 13 week period ended July 1, 2022 and June 25, 2021. Our fiscal year ending September 30, 2022 (fiscal 2022) consists of 53 weeks, and our fiscal year ended September 24, 2021 (fiscal 2021) consisted of 52 weeks.
Recently Issued Accounting Policies	Recently Issued Accounting Standards Adopted Standards Income Taxes. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which modifies and eliminates certain exceptions to the general principles of ASC 740, Income Taxes. We adopted this standard in the first quarter of fiscal 2022, and it did not have a material impact on our condensed consolidated financial statements. Standards Not Yet Adopted Business Combinations. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): A ccounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by an acquirer in accordance with ASC 606, Revenue from Contracts with Customers

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Jul. 01, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table presents a summary of the composition of our revenue for all periods presented (in thousands, except percentage amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended Revenue July 1, 2022 June 25, 2021 July 1, 2022 June 25, 2021 Licensing $ 269,289 93 % $ 271,569 95 % $ 915,406 94 % $ 948,159 95 % Products and services 20,296 7 % 15,230 5 % 60,183 6 % 48,072 5 % Total revenue $ 289,585 100 % $ 286,799 100 % $ 975,589 100 % $ 996,231 100 % The following table presents the composition of our licensing revenue for all periods presented (in thousands, except percentage amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended Market July 1, 2022 June 25, 2021 July 1, 2022 June 25, 2021 Broadcast $ 99,327 37 % $ 123,955 46 % $ 325,441 36 % $ 368,068 39 % Mobile 63,237 23 % 49,861 18 % 204,212 22 % 221,157 23 % CE 38,663 14 % 37,805 14 % 150,192 16 % 138,010 15 % PC 26,947 10 % 24,870 9 % 119,190 13 % 108,709 11 % Other 41,115 16 % 35,078 13 % 116,371 13 % 112,215 12 % Total licensing revenue $ 269,289 100 % $ 271,569 100 % $ 915,406 100 % $ 948,159 100 % We license our technologies in approximately 70 countries, and our licensees distribute products that incorporate our technologies throughout the world. We generate the majority of our revenue from outside the United States ("U.S."). Geographic data for our licensing revenue is based on the location of our licensees’ headquarters, products revenue is based on the destination to which we ship our products, and services revenue is based on the location where services are performed. The following table presents the composition of our revenue by geographic location for all periods presented (in thousands, except percentage amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended Revenue By Geographic Location July 1, 2022 June 25, 2021 July 1, 2022 June 25, 2021 United States $ 78,471 27 % $ 73,355 26 % $ 375,680 39 % $ 327,696 33 % International 211,114 73 % 213,444 74 % 599,909 61 % 668,535 67 % Total revenue $ 289,585 100 % $ 286,799 100 % $ 975,589 100 % $ 996,231 100 %
Contract with Customer, Asset and Liability	The following table presents a summary of the balances to which contract assets and liabilities related to revenue are recorded for all periods presented (in thousands, except percentage amounts): July 1, 2022 September 24, 2021 Change ($) Change (%) Accounts receivable, net $ 236,229 $ 232,609 $ 3,620 2 % Contract assets, net 170,402 182,316 (11,914) (7) % Contract liabilities - current 21,216 18,473 2,743 15 % Contract liabilities - non-current 24,350 23,713 637 3 %

Composition Of Certain Financ_2

Composition Of Certain Financial Statement Captions (Tables)	9 Months Ended
	Jul. 01, 2022
Composition Of Certain Financial Statement Captions [Abstract]
Schedule Of Accounts Receivable	Accounts Receivable and Contract Assets July 1, September 24, Trade accounts receivable $ 148,665 $ 160,112 Accounts receivable from patent administration program licensees 97,136 81,241 Contract assets 170,525 182,524 Accounts receivable, gross and contract assets, gross 416,326 423,877 Less: allowance for credit losses on accounts receivable and contract assets (9,695) (8,952) Total accounts receivable and contract assets, net $ 406,631 $ 414,925
Schedule Of Allowance For Credit Losses	Allowance for Credit Losses Beginning Balance Charges/(Credits) Additions/(Deductions) Ending Balance For fiscal year-to-date period ended: September 24, 2021 $ 15,908 $ (2,889) $ (4,067) $ 8,952 July 1, 2022 8,952 2,166 (852) 10,266 Allowance for credit losses includes the provision for estimated credit losses on our sales-type leases, which was not material as of July 1, 2022 and as of September 24, 2021.
Schedule Of Inventories	Inventories July 1, September 24, Raw materials $ 12,685 $ 2,792 Work in process 4,697 3,461 Finished goods 6,714 4,712 Total inventories $ 24,096 $ 10,965
Schedule Of Prepaid Expenses And Other Current Assets	Prepaid Expenses And Other Current Assets July 1, September 24, Prepaid expenses $ 28,438 $ 29,964 Other current assets 21,485 32,773 Total prepaid expenses and other current assets $ 49,923 $ 62,737
Schedule Of Accrued Liabilities	Accrued Liabilities July 1, September 24, Amounts payable to patent administration program partners $ 77,465 $ 72,847 Accrued compensation and benefits 73,518 107,322 Accrued professional fees 11,802 11,737 Unpaid property, plant, and equipment additions 16,313 17,839 Accrued customer refunds 4,902 14,151 Accrued market development funds 7,728 7,777 Other accrued liabilities 37,539 31,055 Total accrued liabilities $ 229,267 $ 262,728
Schedule Of Other Non-Current Liabilities	Other Non-Current Liabilities July 1, September 24, Supplemental retirement plan obligations $ 4,266 $ 4,877 Non-current tax liabilities (1) 88,801 85,063 Other liabilities 13,252 15,370 Total other non-current liabilities $ 106,319 $ 105,310 (1) Refer to Note 12 " Income Taxes " for additional information related to our tax liabilities.

Investments & Fair Value Meas_2

Investments & Fair Value Measurements (Tables)	9 Months Ended
	Jul. 01, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]
Schedule Of Financial Assets and Liabilities Carried At Fair Value	Our cash and investment portfolio consisted of the following (in thousands): July 1, 2022 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 745,010 $ — $ — $ 745,010 $ 745,010 $ — $ — Cash equivalents: Commercial paper 13,523 — — 13,523 — 13,523 — Money market funds 84,724 — — 84,724 84,724 — — Municipal debt securities 1,003 — — 1,003 — 1,003 — Government bonds 419 — — 419 419 — — U.S. agency securities 14,230 — (4) 14,226 — 14,226 — Cash and cash equivalents 858,909 — (4) 858,905 830,153 28,752 — Short-term investments: Certificate of deposit 15,850 1 (31) 15,820 — 15,820 — U.S. agency securities 1,401 — (16) 1,385 — 1,385 — Government bonds 34,081 — (500) 33,581 29,688 3,893 — Commercial paper 16,092 — (31) 16,061 — 16,061 — Corporate bonds 62,687 — (667) 62,020 — 62,020 — Municipal debt securities 27,992 14 (61) 27,945 — 27,945 — Short-term investments 158,103 15 (1,306) 156,812 29,688 127,124 — Long-term investments: U.S. agency securities 860 — (30) 830 — 830 — Government bonds 44,157 1 (1,548) 42,610 39,913 2,697 — Corporate bonds 26,273 — (980) 25,293 — 25,293 — Municipal debt securities 27,733 59 (383) 27,409 — 27,409 — Other investments (1) 10,584 — — 10,584 — — — Long-term investments 109,607 60 (2,941) 106,726 39,913 56,229 — Total cash, cash equivalents, and investments $ 1,126,619 $ 75 $ (4,251) $ 1,122,443 $ 899,754 $ 212,105 $ — Investments held in supplemental retirement plan: Assets $ 4,364 $ — $ — $ 4,364 $ 4,364 $ — $ — Included in prepaid expenses and other current assets and other non-current assets Liabilities $ 4,364 $ — $ — $ 4,364 $ 4,364 $ — $ — Included in accrued liabilities and other non-current liabilities Currency derivatives as hedge instruments: Assets: Included in other current assets $ — $ 353 $ — $ 353 $ — $ 353 $ — Assets: included in other non-current assets — 119 — 119 — 119 — Liabilities: Included in other accrued liabilities — — (1,318) (1,318) — (1,318) — (1) Other investments as of July 1, 2022 is comprised of an equity method investment and an equity security without a readily determinable fair value measured under the "measurement alternative" (at cost, minus impairment or adjusted for any observable price changes). The equity method investment is measured at cost minus impairment, if any, adjusted for our proportionate share of the investee's net income or loss. Our share of the equity method investee's net income or loss is included in other income/(expense), net on the condensed consolidated statements of operations, and was $3.1 million in the third quarter of fiscal 2022 and was $3.5 million in the year-to-date period ended July 1, 2022. September 24, 2021 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 990,182 $ — $ — $ 990,182 $ 990,182 $ — $ — Cash equivalents: Money market funds 235,198 — — 235,198 235,198 — — Cash and cash equivalents 1,225,380 — — 1,225,380 1,225,380 — — Short-term investments: Certificate of deposit 1,795 — — 1,795 — 1,795 — U.S. agency securities 1,096 6 — 1,102 — 1,102 — Government bonds 100 2 — 102 102 — — Commercial paper 5,184 2 — 5,186 — 5,186 — Corporate bonds 18,850 116 — 18,966 — 18,966 — Municipal debt securities 11,660 29 (1) 11,688 — 11,688 — Short-term investments 38,685 155 (1) 38,839 102 38,737 — Long-term investments: U.S. agency securities 2,264 13 (2) 2,275 — 2,275 — Government bonds 11,784 38 (16) 11,806 4,966 6,840 — Corporate bonds 32,116 61 (25) 32,152 — 32,152 — Municipal debt securities 10,080 58 (8) 10,130 — 10,130 — Other investments (1) 6,456 — — 6,456 — — — Long-term investments 62,700 170 (51) 62,819 4,966 51,397 — Total cash, cash equivalents, and investments $ 1,326,765 $ 325 $ (52) $ 1,327,038 $ 1,230,448 $ 90,134 $ — Investments held in supplemental retirement plan: Assets $ 4,975 $ — $ — $ 4,975 $ 4,975 $ — $ — Included in prepaid expenses and other current assets and other non-current assets Liabilities $ 4,975 $ — $ — $ 4,975 $ 4,975 $ — $ — Included in accrued liabilities and other non-current liabilities Currency derivatives as hedge instruments: Assets: Included in other current assets $ — $ 689 $ — $ 689 $ — $ 689 $ — Liabilities: Included in other accrued liabilities — — (197) (197) — (197) — (1) Other investments as of September 24, 2021 is comprised of one equity method investment, which is measured at cost minus impairment, if any, adjusted for our proportionate share of the investee’s net income or loss. Our share of the investee's net income or loss was not material in the third quarter of fiscal 2021 and was $3.7 million in the year-to-date period ended June 25, 2021.
Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value	The following table presents the gross unrealized losses and fair value for those AFS securities that were in an unrealized loss position for less than twelve months and for twelve months or greater as of July 1, 2022 and September 24, 2021 (in thousands): July 1, 2022 September 24, 2021 Less Than 12 Months 12 Months Or Greater Less Than 12 Months Investment Type Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Certificate of deposit $ 13,367 $ (32) $ — $ — $ 600 $ — U.S. agency securities 15,479 (29) 536 (20) 1,449 (2) Government bonds 72,788 (1,926) 3,300 (122) 8,940 (16) Commercial paper 17,580 (31) — — — — Corporate bonds 79,201 (1,440) 7,788 (206) 22,964 (25) Municipal debt securities 37,949 (420) 476 (24) 7,031 (9) Total $ 236,364 $ (3,878) $ 12,100 $ (372) $ 40,984 $ (52)
Debt Securities, Available-for-sale	The following table summarizes the amortized cost and estimated fair value of the AFS securities within our investment portfolio based on stated maturities as of July 1, 2022 and September 24, 2021, which are recorded within cash equivalents and both short and long-term investments in our condensed consolidated balance sheets (in thousands): July 1, 2022 September 24, 2021 Range of maturity Amortized Cost Fair Value Amortized Cost Fair Value Due within 1 year $ 270,446 $ 269,123 $ 273,884 $ 274,037 Due in 1 to 2 years 61,673 60,081 40,739 40,874 Due in 2 to 5 years 38,911 37,652 15,506 15,490 Total $ 371,030 $ 366,856 $ 330,129 $ 330,401

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	9 Months Ended
	Jul. 01, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	PP&E are recorded at cost, with depreciation expense included in cost of licensing, cost of products and services, R&D, S&M, and G&A expenses in our condensed consolidated statements of operations. As of July 1, 2022 and September 24, 2021, PP&E consisted of the following (in thousands): Property, Plant, and Equipment July 1, September 24, Land $ 41,897 $ 42,041 Buildings and building improvements 286,104 284,146 Leasehold improvements 87,051 88,549 Machinery and equipment 136,763 128,008 Computer equipment and software 268,286 258,981 Furniture and fixtures 33,647 33,565 Equipment provided under operating leases 229,424 214,109 Construction-in-progress 18,193 22,923 Property, plant, and equipment, gross 1,101,365 1,072,322 Less: accumulated depreciation (583,495) (537,941) Property, plant, and equipment, net $ 517,870 $ 534,381

Leases (Tables)

Leases (Tables)	9 Months Ended
	Jul. 01, 2022
Leases [Abstract]
Lease Cost Components, Supplemental Cash Flow Information and Supplemental Balance Sheet Information Schedules	The components of lease expense were as follows (in thousands): Fiscal Quarter Ended Fiscal Year-To-Date Ended July 1, 2022 June 25, 2021 July 1, 2022 June 25, 2021 Lease cost Operating lease cost $ 4,177 $ 4,801 $ 13,335 $ 14,548 Variable lease cost 379 242 1,218 475 Total lease cost $ 4,556 $ 5,043 $ 14,553 $ 15,023 Supplemental cash flow information related to leases was as follows (in thousands): Fiscal Year-To Date Ended July 1, 2022 June 25, 2021 Other information Cash paid for amounts included in the measurement of operating lease liabilities $ 13,147 $ 14,366 Right-of-use assets obtained in exchange for operating lease obligations 1,459 5,013 Supplemental balance sheet information related to leases was as follows: July 1, 2022 September 24, 2021 Operating Leases Weighted-average remaining lease term 5.5 years 5.8 years Weighted-average discount rate 3.1 % 3.1 % Fiscal Quarter Ended Fiscal Year-To-Date Ended July 1, 2022 June 25, 2021 July 1, 2022 June 25, 2021 Operating Lease Income Variable operating lease income $ 10.7 $ 2.7 $ 25.2 $ 3.5 Fixed operating lease income 0.7 1.0 2.3 3.2
Maturities of Lessee Lease Liabilities after Adoption of 842 Schedule	The following table presents the maturity analysis of lease liabilities (in thousands): July 1, 2022 Operating Leases Remainder of Fiscal 2022 $ 4,266 Fiscal 2023 15,549 Fiscal 2024 13,122 Fiscal 2025 9,331 Fiscal 2026 5,778 Thereafter 16,378 Total undiscounted lease payments 64,424 Less: imputed interest (5,836) Total lease liabilities $ 58,588
Maturities of Lessor Operating Lease Payments Schedule	The following table presents the maturity analysis of fixed lease payments due to Dolby (in thousands): July 1, 2022 Operating Leases Sales-Type Leases Remainder of Fiscal 2022 $ 26 $ 1,595 Fiscal 2023 774 1,595 Fiscal 2024 794 795 Fiscal 2025 815 395 Fiscal 2026 732 395 Thereafter — — Total undiscounted cash flows $ 3,141 4,775 Less: present value of lease payments (recognized as lease receivables) (4,333) Difference $ 442
Maturities of Lessor Sales-Type Lease Payments Schedule	The following table presents the maturity analysis of fixed lease payments due to Dolby (in thousands): July 1, 2022 Operating Leases Sales-Type Leases Remainder of Fiscal 2022 $ 26 $ 1,595 Fiscal 2023 774 1,595 Fiscal 2024 794 795 Fiscal 2025 815 395 Fiscal 2026 732 395 Thereafter — — Total undiscounted cash flows $ 3,141 4,775 Less: present value of lease payments (recognized as lease receivables) (4,333) Difference $ 442

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Jul. 01, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table outlines changes to the carrying amount of goodwill (in thousands): Goodwill Balance at September 24, 2021 $ 340,694 Acquired goodwill (1) 31,638 Translation adjustments (4,050) Balance at July 1, 2022 $ 368,282 (1) Refer to Note 16 " Business Combination
Schedule of Finite-Lived Intangible Assets	Intangible assets subject to amortization consisted of the following (in thousands): July 1, 2022 September 24, 2021 Intangible Assets Cost Accumulated Net Cost Accumulated Net Acquired patents and technology $ 361,497 $ (252,896) $ 108,601 $ 343,280 $ (233,789) $ 109,491 Customer relationships 66,178 (55,717) 10,461 65,822 (52,730) 13,092 Other intangible assets 23,012 (22,823) 189 22,972 (22,665) 307 Total $ 450,687 $ (331,436) $ 119,251 $ 432,074 $ (309,184) $ 122,890
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of July 1, 2022, expected amortization expense of our intangible assets in future fiscal periods was as follows (in thousands): Fiscal Year Amortization Expense Remainder of 2022 $ 7,045 2023 26,083 2024 23,954 2025 8,884 2026 7,993 Thereafter 45,292 Total $ 119,251

Stockholders' Equity And Stoc_2

Stockholders' Equity And Stock-Based Compensation (Tables)	9 Months Ended
	Jul. 01, 2022
Stockholders' Equity And Stock-Based Compensation [Abstract]
Summary Of Stock Options Issued To Officers, Directors, And Employees Under 2000 Stock Incentive Plan And 2005 Stock Plan	The following table summarizes information about PSOs granted to our executive officers that have vested: Grant Date Aggregate Shares Granted at Target Award Aggregate Shares Exercisable at Vest Date (1) Percentage Vested of Target Award Vested Date December 15, 2015 419,623 334,623 125 % December 2018 December 15, 2016 276,199 240,539 95 % December 2019 December 15, 2017 264,000 253,440 96 % December 2020 December 15, 2018 241,100 158,700 75 % December 2021 (1) Aggregate shares exercisable at vest date does not include any shares that were cancelled before the vest date after they were granted. The following table summarizes information about stock options, including PSOs, issued under our 2020 Stock Plan: Shares Weighted-Average Weighted-Average Aggregate Intrinsic Value (1) (in thousands) (in years) (in thousands) Options outstanding at September 25, 2021 4,577 $ 59.18 Grants 369 88.37 Exercises (685) 52.97 Forfeitures and cancellations (121) 73.58 Options outstanding at July 1, 2022 4,140 62.38 5.62 $ 47,767 Options vested and expected to vest at July 1, 2022 3,974 61.82 5.54 47,724 Options exercisable at July 1, 2022 3,033 56.26 4.68 46,015 (1) Aggregate intrinsic value is based on the closing stock price of our Class A common stock on July 1, 2022 of $70.82 and excludes the impact of options that were not in-the-money.
Summary Of Restricted Stock Units Issued To Officers, Directors And Employees Under 2005 Stock Incentive Plan	The following table summarizes information about RSUs, including PSUs, issued under our 2020 Stock Plan: Shares Weighted-Average (in thousands) Non-vested at September 24, 2021 3,335 $ 77.46 Granted 1,673 86.93 Vested (1,107) 71.80 Forfeitures (291) 80.27 Non-vested at July 1, 2022 3,610 $ 83.36
Schedule Of Fair Value Of Stock-Based Awards Estimated Using Weighted-Average Assumptions	The weighted-average assumptions used in the determination of the fair value of our stock options were as follows: Fiscal Quarter Ended Fiscal Year-To-Date Ended July 1, July 1, June 25, Expected term (in years) 4.78 4.78 4.88 Risk-free interest rate 3.0 % 1.5 % 0.4 % Expected stock price volatility 29.7 % 28.8 % 28.7 % Dividend yield 1.3 % 1.1 % 1.1 %
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs	The following two tables separately present stock-based compensation expense both by award type and classification in our condensed consolidated statements of operations (in thousands): Expense - By Award Type Fiscal Quarter Ended Fiscal Year-To-Date Ended July 1, June 25, July 1, June 25, Compensation expense Stock options $ 2,321 $ 3,203 $ 7,939 $ 10,913 Restricted stock units (1) 23,715 20,348 75,121 60,594 Employee stock purchase plan 1,572 1,285 4,903 4,055 Total stock-based compensation 27,608 24,836 87,963 75,562 Estimated benefit from income taxes (4,280) (3,944) (13,811) (12,015) Total stock-based compensation, net of tax $ 23,328 $ 20,892 $ 74,152 $ 63,547 (1) Stock-based compensation expense incurred by restricted stock units includes expense from PSUs. Expense - By Income Statement Line Item Classification Fiscal Quarter Ended Fiscal Year-To-Date Ended July 1, June 25, July 1, June 25, Compensation expense Cost of products and services $ 415 $ 426 $ 1,407 $ 1,549 Research and development 9,171 7,296 28,428 22,419 Sales and marketing 9,718 9,286 31,757 28,192 General and administrative 8,304 7,828 26,371 23,402 Total stock-based compensation expense 27,608 24,836 87,963 75,562 Estimated benefit from income taxes (4,280) (3,944) (13,811) (12,015) Total stock-based compensation, net of tax $ 23,328 $ 20,892 $ 74,152 $ 63,547
Schedule of Stock Repurchase Authorizations	The following table summarizes the initial amount of authorized repurchases as well as additional repurchases approved by our Board of Directors as of July 1, 2022 (in thousands): Authorization Period Authorization Amount Fiscal 2010: November 2009 $ 250,000 Fiscal 2010: July 2010 300,000 Fiscal 2011: July 2011 250,000 Fiscal 2012: February 2012 100,000 Fiscal 2015: October 2014 200,000 Fiscal 2017: January 2017 200,000 Fiscal 2018: July 2018 350,000 Fiscal 2019: July 2019 350,000 Fiscal 2021: July 2021 350,000 Fiscal 2022: February 2022 250,000 Total $ 2,600,000
Schedule of Stock Repurchase Activity	The following table provides information regarding share repurchase activity under the program during fiscal 2022: Quarterly Repurchase Activity Shares Cost (1) Average Price Paid Per Share (2) (in thousands) Q1 - Quarter ended December 31, 2021 408,508 $ 35,573 $ 87.08 Q2 - Quarter ended April 1, 2022 1,116,032 84,913 76.08 Q3 - Quarter ended July 1, 2022 2,549,474 190,000 74.53 Total 4,074,014 $ 310,486 (1) Cost of share repurchases includes the price paid per share, and excludes commission costs. (2) Average price paid per share excludes commission costs.
Dividends Declared	The following table summarizes dividends declared under the program during fiscal 2022: Fiscal Period Announcement Date Record Date Payment Date Cash Dividend Per Common Share Dividend Payment Q1 - Quarter ended December 31, 2021 February 3, 2022 February 16, 2022 February 23, 2022 $ 0.25 $25.3 million Q2 - Quarter ended April 1, 2022 May 5, 2022 May 17, 2022 May 25, 2022 $ 0.25 $25.1 million Q3 - Quarter ended July 1, 2022 August 9, 2022 August 23, 2022 August 31, 2022 $ 0.25 $24.7 million (1) (1) The dividend payment amount for the dividend declared in the third quarter of fiscal 2022 is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date.

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Tables)	9 Months Ended
	Jul. 01, 2022
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The following table summarizes the changes in the accumulated balances during the period, and includes information regarding the manner in which the reclassifications out of AOCI into earnings affect our condensed consolidated statements of operations (in thousands): Fiscal Quarter Ended Fiscal Year-To-Date Ended Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Beginning Balance $ (3,800) $ 56 $ (11,937) $ (15,681) $ 220 $ (122) $ (10,128) $ (10,030) Other comprehensive loss before reclassifications: Unrealized losses (414) (362) — (776) (4,971) (6) — (4,977) Foreign currency translation losses (1) — — (13,821) (13,821) — — (15,630) (15,630) Income tax effect - benefit — 97 — 97 — — — — Net of tax (414) (265) (13,821) (14,500) (4,971) (6) (15,630) (20,607) Amounts reclassified from AOCI into earnings: Realized gains/(losses) (2) (15) (314) — (329) 527 (412) — 115 Income tax effect - benefit/(expense) (3) 3 81 — 84 (2) 98 — 96 Net of tax (12) (233) — (245) 525 (314) — 211 Net current-period other comprehensive loss (426) (498) (13,821) (14,745) (4,446) (320) (15,630) (20,396) Ending Balance $ (4,226) $ (442) $ (25,758) $ (30,426) $ (4,226) $ (442) $ (25,758) $ (30,426) Fiscal Quarter Ended Fiscal Year-To-Date Ended Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Beginning Balance $ 458 $ 3,751 $ (8,248) $ (4,039) $ 818 $ 3,969 $ (15,381) $ (10,594) Other comprehensive income/(loss) before reclassifications: Unrealized losses (212) (4,293) — (4,505) (819) (8,203) — (9,022) Foreign currency translation gains — — 937 937 — — 8,577 8,577 Income tax effect - benefit/(expense) 44 115 (110) 49 100 180 (617) (337) Net of tax (168) (4,178) 827 (3,519) (719) (8,023) 7,960 (782) Amounts reclassified from AOCI into earnings: Realized gains (2) 8 2,758 — 2,766 209 6,780 — 6,989 Income tax effect - expense (3) (2) (238) — (240) (12) (633) — (645) Net of tax 6 2,520 — 2,526 197 6,147 — 6,344 Net current-period other comprehensive income/(loss) (162) (1,658) 827 (993) (522) (1,876) 7,960 5,562 Ending Balance $ 296 $ 2,093 $ (7,421) $ (5,032) $ 296 $ 2,093 $ (7,421) $ (5,032) (1) The foreign currency translation losses during the third quarter of fiscal 2022 and the fiscal year-to-date period ended July 1, 2022 were primarily due the strengthening of the U.S. dollar compared to other foreign currencies. (2) Realized gains or losses, if any, from the sale of our AFS investment securities or from foreign currency translation adjustments are included within other income/(expense), net in our condensed consolidated statements of operations. Realized gains or losses on foreign currency contracts designated as cash flow hedges are included in operating expenses in the condensed consolidated statements of operations. (3) The income tax benefit or expense is included within provision for income taxes in our condensed consolidated statements of operations.

Per Share Data (Tables)

Per Share Data (Tables)	9 Months Ended
	Jul. 01, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted EPS attributable to Dolby Laboratories, Inc. (in thousands, except per share amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended July 1, June 25, July 1, June 25, Numerator: Net income attributable to Dolby Laboratories, Inc. $ 39,597 $ 54,621 $ 156,331 $ 266,036 Denominator: Weighted-average shares outstanding—basic 100,213 101,351 100,936 101,177 Potential common shares from options to purchase common stock 779 2,062 1,037 2,033 Potential common shares from restricted stock units 409 1,169 916 1,319 Potential common shares from employee stock purchase plan 73 51 104 78 Weighted-average shares outstanding—diluted 101,474 104,633 102,993 104,607 Net income per share attributable to Dolby Laboratories, Inc.: Basic $ 0.40 $ 0.54 $ 1.55 $ 2.63 Diluted $ 0.39 $ 0.52 $ 1.52 $ 2.54 Antidilutive awards excluded from calculation: Stock options 756 283 552 200 Restricted stock units 2,304 — 1,088 12 Employee stock purchase plan — 1 — 2

Restructuring (Tables)

Restructuring (Tables)	9 Months Ended
	Jul. 01, 2022
Restructuring Charges [Abstract]
Restructuring and Related Costs	The table presented below summarizes the changes in our restructuring accruals (in thousands): Severance Leased facility exit costs and other costs Total Balance at September 25, 2020 $ — $ — $ — Restructuring charges 9,522 718 10,240 Cash payments and adjustments (9,359) (714) (10,073) Balance at September 24, 2021 $ 163 $ 4 $ 167 Restructuring charges 4,336 1,707 6,043 Cash payments and adjustments (3,256) (1,711) (4,967) Balance at July 1, 2022 $ 1,243 $ — $ 1,243

Commitments And Contingencies (

Commitments And Contingencies (Tables)	9 Months Ended
	Jul. 01, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule Of Contractual Obligations And Commitments	The following table presents a summary of our contractual obligations and commitments as of July 1, 2022 (in thousands): Payments Due By Fiscal Period Remainder of Fiscal 2022 Fiscal Fiscal Fiscal Fiscal Thereafter Total Naming rights $ 2,075 $ 12,474 $ 12,794 $ 13,126 $ 13,472 $ 52,850 $ 106,791 Purchase obligations 8,649 27,455 4,809 512 — — 41,425 Donation commitments 1,651 196 116 116 116 503 2,698 Total $ 12,375 $ 40,125 $ 17,719 $ 13,754 $ 13,588 $ 53,353 $ 150,914

Basis Of Presentation (Details)

Basis Of Presentation (Details)	9 Months Ended
	Jul. 01, 2022 segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of Operating Segments	1

Revenue Recognition (Narrative)

Revenue Recognition (Narrative) (Details) $ in Millions	3 Months Ended	9 Months Ended
	Jul. 01, 2022 USD ($)	Jul. 01, 2022 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue adjustment	$ 3
Remaining performance obligation	44.4	$ 44.4
Revenue recognized	$ 2.1	$ 14.2
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-02
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percent	20%	20%
Expected timing of satisfaction period	3 months	3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percent	31%	31%
Expected timing of satisfaction period	1 year	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percent	49%	49%
Expected timing of satisfaction period	1 year	1 year

Revenue Recognition (Schedule o

Revenue Recognition (Schedule of Disaggregation of Revenue) (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2022 USD ($)	Jun. 25, 2021 USD ($)	Jul. 01, 2022 USD ($) country	Jun. 25, 2021 USD ($)
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 289,585	$ 286,799	$ 975,589	$ 996,231
Revenue from contract with customer, percent	100%	100%	100%	100%
Countries technologies are licensed in | country			70
United States
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 78,471	$ 73,355	$ 375,680	$ 327,696
Revenue from contract with customer, percent	27%	26%	39%	33%
International
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 211,114	$ 213,444	$ 599,909	$ 668,535
Revenue from contract with customer, percent	73%	74%	61%	67%
Licensing
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 269,289	$ 271,569	$ 915,406	$ 948,159
Revenue from contract with customer, percent	93%	95%	94%	95%
Revenue from contract with customer, licensing percent	100%	100%	100%	100%
Products and services
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 20,296	$ 15,230	$ 60,183	$ 48,072
Revenue from contract with customer, percent	7%	5%	6%	5%
Broadcast
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 99,327	$ 123,955	$ 325,441	$ 368,068
Revenue from contract with customer, licensing percent	37%	46%	36%	39%
Mobile
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 63,237	$ 49,861	$ 204,212	$ 221,157
Revenue from contract with customer, licensing percent	23%	18%	22%	23%
CE
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 38,663	$ 37,805	$ 150,192	$ 138,010
Revenue from contract with customer, licensing percent	14%	14%	16%	15%
PC
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 26,947	$ 24,870	$ 119,190	$ 108,709
Revenue from contract with customer, licensing percent	10%	9%	13%	11%
Other
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 41,115	$ 35,078	$ 116,371	$ 112,215
Revenue from contract with customer, licensing percent	16%	13%	13%	12%

Revenue Recognition - Summary o

Revenue Recognition - Summary of Contract Assets and Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended
	Jul. 01, 2022	Sep. 24, 2021
Revenue from Contract with Customer [Abstract]
Accounts receivable, net	$ 236,229	$ 232,609
Contract assets, net	170,402	182,316
Contract liabilities	21,216	18,473
Non-current contract liabilities	24,350	$ 23,713
Change ($)
Accounts receivable, net	3,620
Contract assets, net	(11,914)
Contract liabilities - current	2,743
Contract liabilities - non-current	$ 637
Change (%)
Accounts receivable, net	2%
Contract assets, net	(7.00%)
Contract liabilities - current	15%
Contract liabilities - non-current	3%

Composition Of Certain Financ_3

Composition Of Certain Financial Statement Captions (Schedule Of Accounts Receivable) (Details) - USD ($) $ in Thousands	Jul. 01, 2022	Sep. 24, 2021
Composition Of Certain Financial Statement Captions [Abstract]
Trade accounts receivable	$ 148,665	$ 160,112
Accounts receivable from patent administration program licensees	97,136	81,241
Contract assets	170,525	182,524
Accounts receivable, gross and contract assets, gross	416,326	423,877
Less: allowance for credit losses on accounts receivable and contract assets	(9,695)	(8,952)
Total accounts receivable and contract assets, net	$ 406,631	$ 414,925

Composition Of Certain Financ_4

Composition Of Certain Financial Statement Captions (Schedule Of Allowance For Doubtful Accounts) (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Jul. 01, 2022	Sep. 24, 2021
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning Balance	$ 8,952	$ 15,908
Charges/(Credits)  to S&M and G&A	2,166	(2,889)
Additions/(Deductions)	(852)	(4,067)
Ending Balance	$ 10,266	$ 8,952

Composition Of Certain Financ_5

Composition Of Certain Financial Statement Captions (Schedule Of Inventories) (Details) - USD ($) $ in Thousands	Jul. 01, 2022	Sep. 24, 2021
Composition Of Certain Financial Statement Captions [Abstract]
Raw materials	$ 12,685	$ 2,792
Work in process	4,697	3,461
Finished goods	6,714	4,712
Total inventories	$ 24,096	$ 10,965

Composition Of Certain Financ_6

Composition Of Certain Financial Statement Captions (Narrative) (Details) - USD ($) $ in Thousands	Jul. 01, 2022	Sep. 24, 2021
Composition Of Certain Financial Statement Captions [Line Items]
Unbilled Receivables, Current	$ 116,600	$ 97,500
Raw materials	12,685	2,792
Other Noncurrent Assets [Member]
Composition Of Certain Financial Statement Captions [Line Items]
Raw materials	$ 1,300	$ 1,900

Composition Of Certain Financ_7

Composition Of Certain Financial Statement Captions (Schedule Of Prepaid Expenses And Other Current Assets) (Details) - USD ($) $ in Thousands	Jul. 01, 2022	Sep. 24, 2021
Composition Of Certain Financial Statement Captions [Abstract]
Prepaid expenses	$ 28,438	$ 29,964
Other current assets	21,485	32,773
Total prepaid expenses and other current assets	$ 49,923	$ 62,737

Composition Of Certain Financ_8

Composition Of Certain Financial Statement Captions (Schedule Of Accrued Liabilities) (Details) - USD ($) $ in Thousands	Jul. 01, 2022	Sep. 24, 2021
Composition Of Certain Financial Statement Captions [Abstract]
Amounts payable to patent administration program partners	$ 77,465	$ 72,847
Accrued compensation and benefits	73,518	107,322
Accrued professional fees	11,802	11,737
Unpaid property, plant, and equipment additions	16,313	17,839
Accrued customer refunds	4,902	14,151
Accrued market development funds	7,728	7,777
Other accrued liabilities	37,539	31,055
Total accrued liabilities	$ 229,267	$ 262,728

Composition Of Certain Financ_9

Composition Of Certain Financial Statement Captions (Schedule Of Other Non-Current Liabilities) (Details) - USD ($) $ in Thousands	Jul. 01, 2022	Sep. 24, 2021
Composition Of Certain Financial Statement Captions [Abstract]
Supplemental retirement plan obligations	$ 4,266	$ 4,877
Non-current tax liabilities	88,801	85,063
Other liabilities	13,252	15,370
Total other non-current liabilities	$ 106,319	$ 105,310

Investments & Fair Value Meas_3

Investments & Fair Value Measurements (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Jul. 01, 2022	Dec. 31, 2021	Jul. 01, 2022	Jun. 25, 2021	Sep. 24, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents, at Carrying Value	$ 858,909		$ 858,909
Cash and Cash Equivalents, Fair Value Disclosure					$ 1,225,380
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	371,030		371,030		330,129
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	4		4		0
Debt Securities, Available-for-sale	366,856		366,856		330,401
Investment Owned, Unrecognized Unrealized Depreciation	(4,251)		(4,251)		(52)
Cash Cash Equivalents And Investments Total	1,122,443		1,122,443		1,327,038
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0		0
Financial assets carried at fair value	858,905		858,905		1,225,380
Less Than 12 Months, Fair Value	236,364		236,364		40,984
Less Than 12 Months, Gross Unrealized Losses	(3,878)		(3,878)		(52)
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost	270,446		270,446		273,884
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value	269,123		269,123		274,037
Available For Sale Securities Debt Maturities After One Through Two Years Amortized Cost	61,673		61,673		40,739
Available For Sale Securities Debt Maturities After One Through Two Years Fair Value	60,081		60,081		40,874
Available For Sale Securities Debt Maturities After Two Through Three Years Amortized Cost	38,911		38,911		15,506
Available For Sale Securities Debt Maturities After Two Through Three Years Fair Value	37,652		37,652		15,490
Investment Owned, at Cost	1,126,619		1,126,619		1,326,765
Investment Owned, Unrecognized Unrealized Appreciation	75		75		325
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	12,100		12,100
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	372		372
Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	830,153		830,153		1,225,380
Financial assets carried at fair value	899,754		899,754		1,230,448
Derivative Asset					0
Derivative Liability					0
Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	28,752		28,752		0
Financial assets carried at fair value	212,105		212,105		90,134
Derivative Asset					689
Derivative Liability					(197)
Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0		0
Financial assets carried at fair value	0		0
Derivative Asset					0
Derivative Liability					0
Cash [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents, at Carrying Value	745,010		745,010
Cash and Cash Equivalents, Fair Value Disclosure	745,010		745,010		990,182
Cash [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	745,010		745,010		990,182
Cash [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0		0
Cash [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0		0
Commercial Paper [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	13,523		13,523
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	0		0
Debt Securities, Available-for-sale	13,523		13,523
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0		0
Commercial Paper [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0		0
Money Market Funds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure					235,198
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	84,724		84,724
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	0		0
Debt Securities, Available-for-sale	84,724		84,724
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0		0
Money Market Funds [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	84,724		84,724		235,198
Money Market Funds [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0		0
Money Market Funds [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0		0
Municipal Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	1,003		1,003
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	0		0
Debt Securities, Available-for-sale	1,003		1,003
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0		0
Municipal Notes | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0		0
Municipal Notes | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	1,003		1,003
Government Bonds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents, at Carrying Value	419		419
Cash and Cash Equivalents, Fair Value Disclosure	419		419
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	0		0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0		0
Government Bonds [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	419		419
U.S. Agency Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents, at Carrying Value	14,230		14,230
Cash and Cash Equivalents, Fair Value Disclosure	14,226		14,226
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	4		4
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0		0
U.S. Agency Securities [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	0		0
U.S. Agency Securities [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	14,226		14,226
Commercial Paper [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Less Than 12 Months, Fair Value	17,580		17,580		0
Less Than 12 Months, Gross Unrealized Losses	(31)		(31)		0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	0		0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	0		0
Commercial Paper [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure	13,523		13,523
Money Market Funds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents, Fair Value Disclosure					235,198
Government Bonds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Less Than 12 Months, Fair Value	72,788		72,788		8,940
Less Than 12 Months, Gross Unrealized Losses	(1,926)		(1,926)		(16)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	3,300		3,300
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	122		122
U.S. Agency Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Less Than 12 Months, Fair Value	15,479		15,479		1,449
Less Than 12 Months, Gross Unrealized Losses	(29)		(29)		(2)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	536		536
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	20		20
U.S. Agency Securities [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure					0
Short-term Investments [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax					155
Certificates of Deposit [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Less Than 12 Months, Fair Value	13,367		13,367		600
Less Than 12 Months, Gross Unrealized Losses	(32)		(32)		0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	0		0
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	0		0
US Government Agencies Short-term Debt Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	16		16
Debt Securities, Available-for-sale	1,385		1,385		1,102
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0		0
US Government Agencies Short-term Debt Securities [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	0		0
US Government Agencies Short-term Debt Securities [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	1,385		1,385
US Government Agencies Short-term Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	0		0
Corporate Debt Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Less Than 12 Months, Fair Value	79,201		79,201		22,964
Less Than 12 Months, Gross Unrealized Losses	(1,440)		(1,440)		(25)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	7,788		7,788
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	206		206
Municipal Bonds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Less Than 12 Months, Fair Value	37,949		37,949		7,031
Less Than 12 Months, Gross Unrealized Losses	(420)		(420)		(9)
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	476		476
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	24		24
Investments Held In Supplemental Retirement Plan [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial assets carried at fair value	4,364		4,364		4,975
Financial liabilities carried at fair value	4,364		4,364		4,975
Investments Held In Supplemental Retirement Plan [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial assets carried at fair value	0		0
Financial liabilities carried at fair value	0		0
Investments Held In Supplemental Retirement Plan [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Financial assets carried at fair value	0		0
Financial liabilities carried at fair value	0		0
Short-term Investments [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss					38,685
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax					1
Debt Securities, Available-for-sale					38,839
Short-term Investments [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	29,688		29,688		102
Short-term Investments [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	127,124		127,124		38,737
Short-term Investments [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	0		0
Short-term Investments [Member] | Commercial Paper [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	16,092		16,092		5,184
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	31		31		0
Debt Securities, Available-for-sale	16,061		16,061		5,186
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0		0		2
Short-term Investments [Member] | Commercial Paper [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	0		0
Short-term Investments [Member] | Commercial Paper [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	16,061		16,061		5,186
Short-term Investments [Member] | Commercial Paper [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	0		0
Short-term Investments [Member] | Government Bonds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	34,081		34,081		100
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	500		500		0
Debt Securities, Available-for-sale	33,581		33,581		102
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0		0		2
Short-term Investments [Member] | Government Bonds [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	29,688		29,688		102
Short-term Investments [Member] | Government Bonds [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	3,893		3,893		0
Short-term Investments [Member] | Government Bonds [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	0		0
Short-term Investments [Member] | U.S. Agency Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss					1,096
Short-term Investments [Member] | Short-term Investments [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	158,103		158,103
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	1,306		1,306
Debt Securities, Available-for-sale	156,812		156,812
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	15		15
Short-term Investments [Member] | Certificates of Deposit [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	15,850		15,850		1,795
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	31		31		0
Debt Securities, Available-for-sale	15,820		15,820		1,795
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	1		1		0
Short-term Investments [Member] | Certificates of Deposit [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	0		0
Short-term Investments [Member] | Certificates of Deposit [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	15,820		15,820		1,795
Short-term Investments [Member] | Certificates of Deposit [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	0		0
Short-term Investments [Member] | US Government Agencies Short-term Debt Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	1,401		1,401
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax					0
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax					6
Short-term Investments [Member] | US Government Agencies Short-term Debt Securities [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure					1,102
Short-term Investments [Member] | Corporate Debt Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	62,687		62,687		18,850
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	667		667		0
Debt Securities, Available-for-sale	62,020		62,020		18,966
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0		0		116
Short-term Investments [Member] | Corporate Debt Securities [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	0		0
Short-term Investments [Member] | Corporate Debt Securities [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	62,020		62,020		18,966
Short-term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	0		0
Short-term Investments [Member] | Municipal Bonds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	27,992		27,992		11,660
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	61		61		1
Debt Securities, Available-for-sale	27,945		27,945		11,688
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	14		14		29
Short-term Investments [Member] | Municipal Bonds [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	0		0
Short-term Investments [Member] | Municipal Bonds [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	27,945		27,945		11,688
Short-term Investments [Member] | Municipal Bonds [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Fair Value Disclosure	0		0
Long-term Investments [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss					62,700
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax					51
Debt Securities, Available-for-sale					62,819
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax					170
Long-term Investments [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	39,913		39,913		4,966
Long-term Investments [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	56,229		56,229		51,397
Long-term Investments [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	0		0
Long-term Investments [Member] | Government Bonds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	44,157		44,157		11,784
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	1,548		1,548		16
Debt Securities, Available-for-sale	42,610		42,610		11,806
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	1		1		38
Long-term Investments [Member] | Government Bonds [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	39,913		39,913		4,966
Long-term Investments [Member] | Government Bonds [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	2,697		2,697		6,840
Long-term Investments [Member] | Government Bonds [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	0		0
Long-term Investments [Member] | U.S. Agency Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	860		860		2,264
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	30		30		2
Debt Securities, Available-for-sale	830		830		2,275
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0		0		13
Long-term Investments [Member] | U.S. Agency Securities [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	0		0
Long-term Investments [Member] | U.S. Agency Securities [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	830		830		2,275
Long-term Investments [Member] | U.S. Agency Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	0		0
Long-term Investments [Member] | Corporate Debt Securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	26,273		26,273		32,116
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	980		980		25
Debt Securities, Available-for-sale	25,293		25,293		32,152
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0		0		61
Long-term Investments [Member] | Corporate Debt Securities [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	0		0
Long-term Investments [Member] | Corporate Debt Securities [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	25,293		25,293		32,152
Long-term Investments [Member] | Corporate Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	0		0
Long-term Investments [Member] | Municipal Bonds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	27,733		27,733		10,080
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	383		383		8
Debt Securities, Available-for-sale	27,409		27,409		10,130
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	59		59		58
Long-term Investments [Member] | Municipal Bonds [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	0		0
Long-term Investments [Member] | Municipal Bonds [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	27,409		27,409		10,130
Long-term Investments [Member] | Municipal Bonds [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	0		0
Long-term Investments [Member] | Long-term Investments [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	109,607		109,607
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	2,941		2,941
Debt Securities, Available-for-sale	106,726		106,726
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	60		60
Long-term Investments [Member] | Other Long-term Investments [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss	10,584		10,584		6,456
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	0		0		0
Debt Securities, Available-for-sale	10,584		10,584		6,456
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	0		0		0
Net Investment Income	3,100		3,500	$ 3,700
Long-term Investments [Member] | Other Long-term Investments [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	0		0		0
Long-term Investments [Member] | Other Long-term Investments [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	0		0
Long-term Investments [Member] | Other Long-term Investments [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments, Noncurrent, Fair Value Disclosure	0		0
Other Current Assets [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Asset	0		0
Other Current Assets [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Asset	353		353
Other Current Assets [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Asset	0		0
Other Noncurrent Assets [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Asset	0		0
Other Noncurrent Assets [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Asset	119		119
Other Noncurrent Assets [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Asset	0		0
Other Accrued Liabilities | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability	0		0
Other Accrued Liabilities | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability	(1,318)		(1,318)
Other Accrued Liabilities | Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability	0		0
Derivative Financial Instruments, Assets [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Financial Instruments, Assets, Amortized Cost Basis					0
Derivative Financial Instruments, Unrealized Gain					689
Derivative Financial Instruments, Unrealized Loss		$ 0
Derivative Asset					689
Derivative Financial Instruments, Assets [Member] | Other Current Assets [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Financial Instruments, Assets, Amortized Cost Basis	0		0
Derivative Financial Instruments, Unrealized Gain			353
Derivative Financial Instruments, Unrealized Loss			0
Derivative Asset	353		353
Derivative Financial Instruments, Assets [Member] | Other Noncurrent Assets [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Financial Instruments, Assets, Amortized Cost Basis	0		0
Derivative Financial Instruments, Unrealized Gain			119
Derivative Financial Instruments, Unrealized Loss			0
Derivative Asset	119		119
Derivative Financial Instruments, Liabilities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Financial Instruments, Unrealized Gain		$ 0
Derivative Financial Instruments, Unrealized Loss					(197)
Derivative Financial Instruments, Liabilities, Amortized Cost Basis					0
Derivative Liability					$ (197)
Derivative Financial Instruments, Liabilities [Member] | Other Accrued Liabilities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Financial Instruments, Unrealized Gain			0
Derivative Financial Instruments, Unrealized Loss			(1,318)
Derivative Financial Instruments, Liabilities, Amortized Cost Basis	0		0
Derivative Liability	$ (1,318)		$ (1,318)

Property, Plant and Equipment_2

Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Jul. 01, 2022	Sep. 24, 2021
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 1,101,365	$ 1,072,322
Less: accumulated depreciation	(583,495)	(537,941)
Property, plant, and equipment, net	517,870	534,381
Land
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	41,897	42,041
Buildings and building improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	286,104	284,146
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	87,051	88,549
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	136,763	128,008
Computer equipment and software
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	268,286	258,981
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	33,647	33,565
Equipment provided under operating leases
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	229,424	214,109
Construction-in-progress
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 18,193	$ 22,923

Leases (Narrative) (Details)

Leases (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021
Lessor, Lease, Description [Line Items]
Lesse lease term	10 years		10 years
Lessee lease renewal term	5 years		5 years
Lessee lease termination period			1 year
Variable operating lease income	$ 10.7	$ 2.7	$ 25.2	$ 3.5
Fixed operating lease income	$ 0.7	$ 1	$ 2.3	$ 3.2
Minimum [Member]
Lessor, Lease, Description [Line Items]
Lessor lease term	4 years		4 years
Lessor lease renewal term	1 year		1 year
Maximum [Member]
Lessor, Lease, Description [Line Items]
Lessor lease term	10 years		10 years
Lessor lease renewal term	5 years		5 years

Leases (Lease Cost Components)

Leases (Lease Cost Components) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021
Leases [Abstract]
Operating lease cost	$ 4,177	$ 4,801	$ 13,335	$ 14,548
Variable lease cost	379	242	1,218	475
Total lease cost	$ 4,556	$ 5,043	$ 14,553	$ 15,023

Leases (Supplemental Cash Flow

Leases (Supplemental Cash Flow Information Schedule) (Details) - USD ($) $ in Thousands	9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021
REMOVE
Cash paid for amounts included in the measurement of operating lease liabilities	$ 13,147	$ 14,366
REMOVE
Right-of-use assets obtained in exchange for operating lease obligations	$ 1,459	$ 5,013

Leases (Supplemental Balance Sh

Leases (Supplemental Balance Sheet Information Schedule) (Details)	Jul. 01, 2022	Sep. 24, 2021
Operating Leases
Weighted-average remaining lease term	5 years 6 months	5 years 9 months 18 days
Weighted-average discount rate	3.10%	3.10%

Leases (Maturities of Lessee Le

Leases (Maturities of Lessee Lease Liabilities Schedule) (Details) $ in Thousands	Jul. 01, 2022 USD ($)
Operating Leases
Remainder of Fiscal 2022	$ 4,266
Fiscal 2023	15,549
Fiscal 2024	13,122
Fiscal 2025	9,331
Fiscal 2026	5,778
Thereafter	16,378
Total undiscounted lease payments	64,424
Less: imputed interest	(5,836)
Total lease liabilities	$ 58,588

Leases (Maturities of Lessor Le

Leases (Maturities of Lessor Lease Payments Schedule) (Details) $ in Thousands	Jul. 01, 2022 USD ($)
Operating Leases
Remainder of Fiscal 2022	$ 26
Fiscal 2023	774
Fiscal 2024	794
Fiscal 2025	815
Fiscal 2026	732
Thereafter	0
Total undiscounted cash flows	3,141
Sales-Type Leases
Remainder of Fiscal 2022	1,595
Fiscal 2023	1,595
Fiscal 2024	795
Fiscal 2025	395
Fiscal 2026	395
Thereafter	0
Total undiscounted cash flows	4,775
Less: present value of lease payments (recognized as lease receivables)	(4,333)
Difference	$ 442

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets Goodwill Rollforward (Details) $ in Thousands	9 Months Ended
	Jul. 01, 2022 USD ($)
Goodwill [Roll Forward]
Balance at September 24, 2021	$ 340,694
Acquired goodwill	31,638
Translation adjustments	(4,050)
Balance at July 1, 2022	$ 368,282

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	Jul. 01, 2022	Sep. 24, 2021
Finite-Lived Intangible Assets [Line Items]
Cost	$ 450,687	$ 432,074
Accumulated Amortization	(331,436)	(309,184)
Net	119,251	122,890
Acquired patents and technology
Finite-Lived Intangible Assets [Line Items]
Cost	361,497	343,280
Accumulated Amortization	(252,896)	(233,789)
Net	108,601	109,491
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Cost	66,178	65,822
Accumulated Amortization	(55,717)	(52,730)
Net	10,461	13,092
Other intangible assets
Finite-Lived Intangible Assets [Line Items]
Cost	23,012	22,972
Accumulated Amortization	(22,823)	(22,665)
Net	$ 189	$ 307

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets Future Amortization Expense (Details) - USD ($) $ in Thousands	Jul. 01, 2022	Sep. 24, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2022	$ 7,045
2023	26,083
2024	23,954
2025	8,884
2026	7,993
Thereafter	45,292
Net	$ 119,251	$ 122,890

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets Intangible Assets, Additions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Purchases of intangible assets			$ 11.5
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			16 years
Amortization of Intangible Assets	$ 6.6	$ 7.3	$ 22.2	$ 21.9

Stockholders' Equity And Stoc_3

Stockholders' Equity And Stock-Based Compensation (Narrative) (Details)				9 Months Ended	41 Months Ended
	Dec. 15, 2021 shares	Dec. 15, 2020 shares	Dec. 16, 2019 shares	Jul. 01, 2022 USD ($) vote shares	Mar. 28, 2014	Sep. 24, 2021 shares
Stockholders' Equity And Stock-Based Compensation [Line Items]
Options outstanding to purchase						4,577,000
Remaining authorization to purchase additional shares | $				$ 230,900,000
Stock options
Stockholders' Equity And Stock-Based Compensation [Line Items]
Stock options expected to vest | $				$ 15,300,000
Employee stock options expected to be recognized over a weighted-average period				2 years 4 months 24 days
Performance-Based Stock Options [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period				7 years
Compensation requisite measurement period				3 years
Shares exercisable (in shares)				424,249
Restricted stock units
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period				4 years
Stock options expected to vest | $				$ 211,500,000
Employee stock options expected to be recognized over a weighted-average period				2 years 7 months 6 days
Restricted stock units | Employees and Officers [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period				4 years
Restricted stock units | Awards Granted Prior to November 2010 [Member] | Directors [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period					1 year
Performance-Based Restricted Stock Units [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Compensation requisite measurement period				3 years
Performance-Based Restricted Stock Units [Member] | Executive Officer [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Percentage Vested of Target Award	200%	200%	200%	200%
Shares exercisable (in shares)	120,602	132,276	124,000
Options outstanding to purchase	60,301	66,138	62,000	162,846
Performance-Based Restricted Stock Units [Member] | Vesting Shares At 200% Of The Target Award Amount | Executive Officer [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Options outstanding to purchase				325,692
Awards Granted Under 2005 Stock Plan Prior To February 2011 [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Terms for issuance of stock (in shares)				2
Awards Granted Under 2005 Stock Plan From February 2011 [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Terms for issuance of stock (in shares)				1.6
Employee stock purchase plan
Stockholders' Equity And Stock-Based Compensation [Line Items]
Percentage of compensation withheld by employees to purchase common stock				10%
Discount from market price on purchase date				15%
Class A Common Stock [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Common stock, shares authorized (shares)				500,000,000		500,000,000
Common stock, shares issued (shares)				62,578,760		64,986,316
Common stock, shares outstanding (shares)				62,578,760		64,986,316
Common stock, number of votes per share | vote				1
Class A Common Stock [Member] | 2005 Stock Plan. [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Shares authorized under plan				55,000,000
Options outstanding to purchase				4,140,000
Class A Common Stock [Member] | Employee stock purchase plan
Stockholders' Equity And Stock-Based Compensation [Line Items]
Maximum value of common stock available for eligible employees | $				$ 25,000
Maximum number of common stock available for eligible employees (in shares)				1,000
Purchase period				6 months
Look back commencement period				1 year
Class B Common Stock [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Common stock, shares authorized (shares)				500,000,000		500,000,000
Common stock, shares issued (shares)				36,086,629		36,086,779
Common stock, shares outstanding (shares)				36,086,629		36,086,779
Common stock, number of votes per share | vote				10
Options Granted From June Two Thousand Eight Member | Stock options
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period				4 years
Options Granted From June Two Thousand Eight Member | Stock options | One year anniversary date
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period				1 year
Percentage of stock option becoming exercisable subjected to date of grant				25%
Options Granted From June Two Thousand Eight Member | Stock options | Over 36 equally installment periods following one year anniversary date
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period				36 months
Awards Granted After November 2010 Member [Member] | Restricted stock units
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period				1 year
Minimum [Member] | Performance-Based Stock Options [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Percentage Vested of Target Award				0%
Minimum [Member] | Performance-Based Restricted Stock Units [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Percentage Vested of Target Award				0%
Minimum [Member] | Options Granted From June Two Thousand Eight Member | Stock options
Stockholders' Equity And Stock-Based Compensation [Line Items]
Options expiration period				3 months
Maximum [Member] | Performance-Based Stock Options [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Percentage Vested of Target Award				125%
Maximum [Member] | Performance-Based Restricted Stock Units [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Percentage Vested of Target Award				200%
Maximum [Member] | Options Granted From June Two Thousand Eight Member | Stock options
Stockholders' Equity And Stock-Based Compensation [Line Items]
Options expiration period				10 years

Stockholders' Equity And Stoc_4

Stockholders' Equity And Stock-Based Compensation (Summary Of Stock Options Issued To Officers, Directors, And Employees Under 2000 Stock Incentive Plan And 2005 Stock Plan) (Details) - USD ($) $ / shares in Units, $ in Thousands					9 Months Ended
	Dec. 15, 2018	Dec. 15, 2017	Dec. 15, 2016	Dec. 15, 2015	Jul. 01, 2022
Shares
Shares, Options outstanding at beginning of period (in shares)					4,577,000
Shares, Grants (in shares)					369,000
Shares, Exercises (in shares)					(685,000)
Shares, Forfeitures and cancellations (in shares)					(121,000)
Shares, Options vested and expected to vest (in shares)					3,974,000
Weighted-Average Exercise Price
Weighted Average Exercise Price, Options outstanding at beginning of period (in usd per share)					$ 59.18
Weighted Average Exercise Price, Grants (in usd per share)					88.37
Weighted Average Exercise Price, Exercises (in usd per share)					52.97
Weighted Average Exercise Price, Forfeitures and cancellations (in usd per share)					73.58
Weighted Average Exercise Price, Options outstanding at end of period (in usd per share)					62.38
Weighted Average Exercise Price, Options vested and expected to vest (in usd per share)					61.82
Weighted Average Exercise Price, Options exercisable (in usd per share)					$ 56.26
Weighted Average Remaining Contractual Life, Options vested and expected to vest at end of period					5 years 6 months 14 days
Weighted Average Remaining Contractual Life, Options exercisable					4 years 8 months 4 days
Aggregate Intrinsic Value, Options outstanding					$ 47,767
Aggregate Intrinsic Value, Options vested and expected to vest					47,724
Aggregate Intrinsic Value, Options exercisable					$ 46,015
Year End Stock Price (in dollars per share)					$ 70.82
2005 Stock Plan. [Member] | Class A Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options vested and exercisable (in shares)					3,033,000
Weighted average remaining contractual life					5 years 7 months 13 days
Shares
Shares, Options outstanding at end of period (in shares)					4,140,000
Weighted-Average Exercise Price
Weighted Average Remaining Contractual Life, Options outstanding					5 years 7 months 13 days
Performance-Based Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares exercisable (in shares)					424,249
Performance-Based Stock Options [Member] | Executive Officer [Member] | December 15, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate Shares Granted at Target Award (in shares)				419,623
Options vested and exercisable (in shares)				334,623
Percentage Vested of Target Award				125%
Performance-Based Stock Options [Member] | Executive Officer [Member] | December 15, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate Shares Granted at Target Award (in shares)			276,199
Shares exercisable (in shares)			240,539
Percentage Vested of Target Award			95%
Performance-Based Stock Options [Member] | Executive Officer [Member] | December 15, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate Shares Granted at Target Award (in shares)		264,000
Shares exercisable (in shares)		253,440
Percentage Vested of Target Award		96%
Performance-Based Stock Options [Member] | Executive Officer [Member] | December 15, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate Shares Granted at Target Award (in shares)	241,100
Shares exercisable (in shares)	158,700
Percentage Vested of Target Award	75%

Stockholders' Equity And Stoc_5

Stockholders' Equity And Stock-Based Compensation (Summary Of Restricted Stock Units Issued To Officers, Directors, And Employees Under 2005 Stock Incentive Plan) (Details) shares in Thousands	9 Months Ended
	Jul. 01, 2022 $ / shares shares
Shares
Shares, Non-vested at beginning of period (in shares) | shares	3,335
Shares, Granted (in shares) | shares	1,673
Shares, Vested (in shares) | shares	(1,107)
Shares, Forfeitures (in shares) | shares	(291)
Shares, Non-vested at end of period (in shares) | shares	3,610
Weighted-Average Grant Date Fair Value
Weighted Average Fair Value, Non-vested at beginning of period (in dollars per share) | $ / shares	$ 77.46
Weighted Average Fair Value, Granted (in dollars per share) | $ / shares	86.93
Weighted Average Fair Value, Vested (in dollars per share) | $ / shares	71.80
Weighted Average Fair Value, Forfeitures (in dollars per share) | $ / shares	80.27
Weighted Average Fair Value, Non-vested at end of period (in dollars per share) | $ / shares	$ 83.36

Stockholders' Equity And Stoc_6

Stockholders' Equity And Stock-Based Compensation (Schedule Of Fair Value Of Stock-Based Awards Estimated Using Weighted-Average Assumptions) (Details)	3 Months Ended	9 Months Ended
	Jul. 01, 2022	Jul. 01, 2022	Jun. 25, 2021
Stockholders' Equity And Stock-Based Compensation [Abstract]
Expected term (in years)	4 years 9 months 10 days	4 years 9 months 10 days	4 years 10 months 17 days
Risk-free interest rate	3%	1.50%	0.40%
Expected stock price volatility	29.70%	28.80%	28.70%
Dividend yield	1.30%	1.10%	1.10%

Stockholders' Equity And Stoc_7

Stockholders' Equity And Stock-Based Compensation (Schedule Of Stock-Based Compensation Expense By Plan) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021
Stockholders' Equity And Stock-Based Compensation [Line Items]
Total stock-based compensation	$ 27,608	$ 24,836	$ 87,963	$ 75,562
Estimated benefit from income taxes	(4,280)	(3,944)	(13,811)	(12,015)
Total stock-based compensation, net of tax	23,328	20,892	74,152	63,547
Stock options
Stockholders' Equity And Stock-Based Compensation [Line Items]
Total stock-based compensation	2,321	3,203	7,939	10,913
Restricted stock units
Stockholders' Equity And Stock-Based Compensation [Line Items]
Total stock-based compensation	23,715	20,348	75,121	60,594
Employee stock purchase plan
Stockholders' Equity And Stock-Based Compensation [Line Items]
Total stock-based compensation	$ 1,572	$ 1,285	$ 4,903	$ 4,055

Stockholders' Equity And Stoc_8

Stockholders' Equity And Stock-Based Compensation (Schedule of Stock-Based Compensation By Classification) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation	$ 27,608	$ 24,836	$ 87,963	$ 75,562
Estimated benefit from income taxes	(4,280)	(3,944)	(13,811)	(12,015)
Total stock-based compensation, net of tax	23,328	20,892	74,152	63,547
Cost of products and services
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation	415	426	1,407	1,549
Research and development
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation	9,171	7,296	28,428	22,419
Sales and marketing
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation	9,718	9,286	31,757	28,192
General and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation	$ 8,304	$ 7,828	$ 26,371	$ 23,402

Stockholders' Equity And Stoc_9

Stockholders' Equity And Stock-Based Compensation (Stock Repurchase Authorizations) (Details) - USD ($) $ in Thousands	Jul. 01, 2022	Feb. 03, 2022	Jul. 29, 2021	Jul. 31, 2019	Jul. 25, 2018	Jan. 25, 2017	Oct. 31, 2014	Feb. 29, 2012	Jul. 31, 2011	Jul. 31, 2010	Nov. 30, 2009
Equity, Class of Treasury Stock [Line Items]
Authorization Amount	$ 2,600,000										$ 250,000
Additional Stock Approved [Member]
Equity, Class of Treasury Stock [Line Items]
Authorization Amount		$ 250,000	$ 350,000	$ 350,000	$ 350,000	$ 200,000	$ 200,000	$ 100,000	$ 250,000	$ 300,000

Stockholders' Equity And Sto_10

Stockholders' Equity And Stock-Based Compensation (Stock Repurchase) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended			9 Months Ended
	Jul. 01, 2022	Apr. 01, 2022	Dec. 31, 2021	Jul. 01, 2022	Jun. 25, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares repurchased (in shares)				4,074,014
Payments for Repurchase of Common Stock	$ 190,000	$ 84,913	$ 35,573	$ 310,486	$ 149,764
Repurchase of common stock				$ 310,486
Stock Repurchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares repurchased (in shares)	2,549,474	1,116,032	408,508
Average Price Paid per Share (in dollars per share)	$ 74.53	$ 76.08	$ 87.08	$ 74.53

Stockholders' Equity and Sto_11

Stockholders' Equity and Stock-Based Compensation - Dividends (Details) - USD ($) $ / shares in Units, $ in Millions							3 Months Ended		9 Months Ended
	Aug. 31, 2022	Aug. 09, 2022	May 25, 2022	May 05, 2022	Feb. 23, 2022	Feb. 03, 2022	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021
Dividends Payable [Line Items]
Cash dividend declared per common share (in dollars per share)				$ 0.25		$ 0.25	$ 0.25	$ 0.22	$ 0.75	$ 0.66
Dividend Payment			$ 25.1		$ 25.3
Subsequent Event
Dividends Payable [Line Items]
Cash dividend declared per common share (in dollars per share)		$ 0.25
Dividend Payment	$ 24.7

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	$ (15,681)	$ (4,039)	$ (10,030)	$ (10,594)
Unrealized gains (losses) and Foreign currency translation gains (losses)	(776)	(4,505)	(4,977)	(9,022)
Income tax effect - benefit/(expense)	97	49	0	(337)
Net of tax	(14,500)	(3,519)	(20,607)	(782)
Realized gains/(losses)	(329)	2,766	115	6,989
Income tax effect - benefit/(expense)	84	(240)	96	(645)
Net of tax	(245)	2,526	211	6,344
Net current-period other comprehensive loss	(14,745)	(993)	(20,396)	5,562
Ending Balance	(30,426)	(5,032)	(30,426)	(5,032)
Investment Securities
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	(3,800)	458	220	818
Unrealized gains (losses) and Foreign currency translation gains (losses)	(414)	(212)	(4,971)	(819)
Income tax effect - benefit/(expense)	0	44	0	100
Net of tax	(414)	(168)	(4,971)	(719)
Realized gains/(losses)	(15)	8	527	209
Income tax effect - benefit/(expense)	3	(2)	(2)	(12)
Net of tax	(12)	6	525	197
Net current-period other comprehensive loss	(426)	(162)	(4,446)	(522)
Ending Balance	(4,226)	296	(4,226)	296
Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	56	3,751	(122)	3,969
Unrealized gains (losses) and Foreign currency translation gains (losses)	(362)	(4,293)	(6)	(8,203)
Income tax effect - benefit/(expense)	97	115	0	180
Net of tax	(265)	(4,178)	(6)	(8,023)
Realized gains/(losses)	(314)	2,758	(412)	6,780
Income tax effect - benefit/(expense)	81	(238)	98	(633)
Net of tax	(233)	2,520	(314)	6,147
Net current-period other comprehensive loss	(498)	(1,658)	(320)	(1,876)
Ending Balance	(442)	2,093	(442)	2,093
Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	(11,937)	(8,248)	(10,128)	(15,381)
Unrealized gains (losses) and Foreign currency translation gains (losses)	(13,821)	937	(15,630)	8,577
Income tax effect - benefit/(expense)	0	(110)	0	(617)
Net of tax	(13,821)	827	(15,630)	7,960
Net current-period other comprehensive loss	(13,821)	827	(15,630)	7,960
Ending Balance	$ (25,758)	$ (7,421)	$ (25,758)	$ (7,421)

Per Share Data (Details)

Per Share Data (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Net income attributable to Dolby Laboratories, Inc.	$ 39,597	$ 54,621	$ 156,331	$ 266,036
Weighted average shares outstanding-basic (in shares)	100,213	101,351	100,936	101,177
Potential common shares from options to purchase common stock (in shares)	779	2,062	1,037	2,033
Potential common shares from restricted stock units (in shares)	409	1,169	916	1,319
Potential common shares from ESPP (in shares)	73	51	104	78
Weighted average shares outstanding-diluted (in shares)	101,474	104,633	102,993	104,607
Net income per share attributable to Dolby Laboratories, Inc. - Basic (in usd per share)	$ 0.40	$ 0.54	$ 1.55	$ 2.63
Net income per share attributable to Dolby Laboratories, Inc. - Diluted (in usd per share)	$ 0.39	$ 0.52	$ 1.52	$ 2.54
Stock options
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Anti-dilutive securities, excluded from calculations (in shares)	756	283	552	200
Restricted stock units
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Anti-dilutive securities, excluded from calculations (in shares)	2,304	0	1,088	12
Employee stock purchase plan
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Anti-dilutive securities, excluded from calculations (in shares)	0	1	0	2

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021	Sep. 24, 2021
Income Tax Disclosure [Abstract]
Unrecognized tax benefits, gross	$ 68,100		$ 68,100		$ 66,100
Unrecognized tax benefits if recognized, would affect our effective tax rate	$ 47,800		$ 47,800		$ 43,600
Effective tax rate (as a percent)	19.80%	7.70%	15.30%	12.20%
Provision (benefit) for income taxes	$ (9,802)	$ (4,565)	$ (28,166)	$ (37,859)
Federal tax rate	21%

Restructuring (Details)

Restructuring (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Jul. 01, 2022	Jun. 25, 2021	Jul. 01, 2022	Jun. 25, 2021	Sep. 24, 2021
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance			$ 167	$ 0	$ 0
Restructuring charges	$ 976	$ 140	6,043	10,904	10,240
Cash payments and adjustments			(4,967)		(10,073)
Restructuring reserve, ending balance	1,243		1,243		167
Severance
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance			163	0	0
Restructuring charges			4,336		9,522
Cash payments and adjustments			(3,256)		(9,359)
Restructuring reserve, ending balance	1,243		1,243		163
Leased facility exit costs and other costs
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance			4	$ 0	0
Restructuring charges			1,707		718
Cash payments and adjustments			(1,711)		(714)
Restructuring reserve, ending balance	$ 0		$ 0		$ 4

Commitments And Contingencies_2

Commitments And Contingencies (Schedule Of Contractual Obligations And Commitments) (Details) $ in Thousands	Jul. 01, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of Fiscal 2022	$ 2,075
Naming rights, Fiscal 2023	12,474
Naming rights, Fiscal 2024	12,794
Naming rights, Fiscal 2025	13,126
Naming rights, Fiscal 2026	13,472
Naming rights, Thereafter	52,850
Naming rights, Total	106,791
Purchase obligation, Remainder of 2022	8,649
Purchase obligation, Fiscal 2023	27,455
Purchase obligation, Fiscal 2024	4,809
Purchase Obligation, Fiscal 2025	512
Purchase obligation, Fiscal 2026	0
Purchase obligation, Thereafter	0
Purchase obligation, Total	41,425
Donation commitments, Remainder of Fiscal 2022	1,651
Donation commitments, Fiscal 2023	196
Donation commitments, Fiscal 2024	116
Donation commitments, Fiscal 2025	116
Donation commitments, Fiscal 2026	116
Donation commitments, Thereafter	503
Donation commitments, Total	2,698
Total, due in Remainder of Fiscal 2022	12,375
Total, due in Fiscal 2023	40,125
Total, due in Fiscal 2024	17,719
Total, due in Fiscal 2025	13,754
Total, due in Fiscal 2026	13,588
Total, due Thereafter	53,353
Total due	$ 150,914

Commitments And Contingencies_3

Commitments And Contingencies (Narrative) (Details) $ in Millions	9 Months Ended
	Jul. 01, 2022 USD ($)
Other Commitments [Line Items]
Litigation Settlement, Expense	$ 34.4
Naming Rights
Other Commitments [Line Items]
Term of agreement	20 years
Donation Commitments
Other Commitments [Line Items]
Term of agreement	15 years

Subsequent Event (Details)

Subsequent Event (Details) - USD ($) $ in Millions	Aug. 09, 2022	Jul. 01, 2022
Subsequent Event [Line Items]
Stock Repurchase Program, Remaining Authorized Repurchase Amount		$ 230.9
Subsequent Event | Class A Common Stock [Member]
Subsequent Event [Line Items]
Increase in stock repurchase program	$ 350
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 581

Business Combinations (Narrativ

Business Combinations (Narrative) (Details) - USD ($) $ in Thousands		9 Months Ended
	Jan. 31, 2022	Jul. 01, 2022	Jun. 25, 2021	Sep. 24, 2021
Business Acquisition, Contingent Consideration [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired		$ 38,171	$ 0
Goodwill		$ 368,282		$ 340,694
Millicast, Inc.
Business Acquisition, Contingent Consideration [Line Items]
Payments to Acquire Businesses, Net of Cash Acquired	$ 38,800
Finite-lived Intangible Assets Acquired	8,700
Goodwill	$ 31,700
Fair Value Measurements, Nonrecurring, Measurement Period	one year
Millicast, Inc. | Minimum [Member]
Business Acquisition, Contingent Consideration [Line Items]
Finite-Lived Intangible Asset, Useful Life	1 year 6 months
Millicast, Inc. | Maximum [Member]
Business Acquisition, Contingent Consideration [Line Items]
Finite-Lived Intangible Asset, Useful Life	8 years